POPULARITY
Categories
Dr. Patricia Tan serves as Medical Director for Rusk Pediatrics Rehabilitation. Her Certification is from the American Board of Physical Medicine & Rehabilitation. She has been selected as a Fellow by the following organizations: American Academy of Physical Medicine and Rehabilitation; American Academy of Pediatrics; American Academy of Cerebral Palsy and Developmental Medicine; and the Association of Academic Physiatrists. Her medical degree is from the University of Santo Tomas in Manila, Philippines. Dr. Megan Conklin is Associate Director of Rusk Pediatric Therapy Services at NYU Langone. She works collaboratively with an interdisciplinary team across the spectrum of pediatric diagnoses from birth through the transition into adulthood. She has a Doctor of Physical Therapy degree, 20 years of clinical experience at NYU; and is certified as a clinical specialist in pediatric physical therapy by the American Board of Physical Therapy Specialties of the American Physical Therapy Association. Part 2 The discussion included the following topics: quality measures used to determine if desired outcomes are being achieved; challenges or potential downsides associated with a transition from pediatric to adult care; integration of artificial intelligence into pediatric rehabilitation; and current pediatric research conducted at NYU.
Enuresis, or bedwetting, is one of the most common concerns encountered in pediatrics. It can present as nighttime bedwetting, daytime urinary accidents, or a combination of both. Oftentimes, families and clinicians are left wondering what's typical and what's considered concerning. In this episode, we focus on the evaluation and management of enuresis in children. Each case is influenced by a range of factors including fluid intake, bowel habits, sleep quality and lifestyle routines. While first-line, non-pharmacologic strategies are the cornerstone of care, effective treatment requires attention to detail and a comprehensive approach. This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. In this episode, we are joined by Julie Cheng, MD, an Assistant Professor of Urology at Seattle Children's Hospital and the University of Washington. Some highlights from this episode include: Differentiating between types of enuresis How key elements in pediatric history and physical examination can help diagnose the problem Evidence-based first-line interventions and when to escalate care The role behavioral factors, such as sleep or screen time, play in enuresis For more information on Children's Colorado, visit: childrenscolorado.org.
In this episode of The Virtual Curbside, host Paul Wirkus, MD, FAAP, is joined by Kyla Clark, Strengthening Families Program Administrator, provides an inside look at how the Division of Child and Family Services (DCFS) works to protect children and support families. She explains the different types of foster care placements, the circumstances under which children may be removed from their homes, and the efforts made to reunify families whenever possible. This conversation helps listeners understand the purpose of child welfare, the goals of DCFS, and how the system strives to balance child safety with family preservation. Have a question? Email questions@vcurb.com. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP. Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This week on Rewild Your Business I'm joined by the incredible Claire Schwartz – grief and trauma coach and healer. Claire brings not only decades of professional expertise, but also the lived wisdom of her own journey through loss and trauma survival. Together, we dive into a conversation most business owners avoid until life forces it upon them:
Send us a message with this link, we would love to hear from you. Standard message rates may apply. We unpack myths, the new stepwise approach, and why return to school should come before return to play.• what a concussion is• common and delayed symptoms including mood and sleep changes• immediate sideline steps• why “cocooning” is outdated and how light activity helps• individualized recovery timelines and risk of returning too soon• return-to-learn before return-to-play with simple accommodations• a staircase model for activity and symptom thresholds• helmets vs brain movement and the role of honest reporting• practical tips for coaches, parents, and student athletesCheck out our website, send us an email, share this with a friend or young student athlete who is playing some sports and might get a concussionReferencesBroglio SP, Register-Mihalik JK, Guskiewicz KM, et al. National Athletic Trainers' Association Bridge Statement: Management of Sport-Related Concussion. Journal of Athletic Training. 2024;59(3):225-242. doi:10.4085/1062-6050-0046.22.Centers for Disease Control and Prevention Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children. Lumba-Brown A, Yeates KO, Sarmiento K, et al. JAMA Pediatrics. 2018;172(11):e182853. doi:10.1001/jamapediatrics.2018.2853.Feiss R, Lutz M, Reiche E, Moody J, Pangelinan M. A Systematic Review of the Effectiveness of Concussion Education Programs for Coaches and Parents of Youth Athletes. International Journal of Environmental Research and Public Health. 2020;17(8):E2665. doi:10.3390/ijerph17082665.Gereige RS, Gross T, Jastaniah E. Individual Medical Emergencies Occurring at School. Pediatrics. 2022;150(1):e2022057987. doi:10.1542/peds.2022-057987.Giza CC, Kutcher JS, Ashwal S, et al. Summary of Evidence-Based Guideline Update: Evaluation and Management of Concussion in Sports: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;80(24):2250-2257. doi:10.1212/WNL.0b013e31828d57dd.Halstead ME. What's New With Pediatric Sport Concussions? Pediatrics. 2024;153(1):e2023063881. doi:10.1542/peds.2023-063881.Halstead ME, Walter KD, Moffatt K. Sport-Related Concussion in Children and Adolescents. Pediatrics. 2018;142(6):e20183074. doi:10.1542/peds.2018-3074.Leddy JJ. Sport-Related Concussion. The New England Journal of Medicine. 2025;392(5):483-493. doi:10.1056/NEJMcp2400691.McCrea M, Broglio S, McAllister T, et al. Return to Play and Risk of Repeat Concussion in Collegiate Football Players: Comparative Analysis From the NCAA Concussion Study (1999–2001) and CARE Consortium (2014–2017). British Journal of Sports Medicine. 2020;54(2):102-109. doi:10.1136/bjsports-2019-100579.Scorza KA, Cole W. Current Concepts in Concussion: Initial Evaluation and Management. American Family Physician. 2019;99(7):426-434.Shirley E, Hudspeth LJ, Maynard JR. Managing Sports-Related Concussions From Time of Injury Through Return to Play. The Journal of the American Academy of Orthopaedic Surgeons. 2018;26(13):e279-e286. doi:10.5435/JAAOS-D-16-00684.Zhou H, Ledsky R, Sarmiento K, et al. Parent-Child Communication About ConcussSupport the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski
October – will history repeat? New tariffs announced - again. Thinking about 401k plans - innovation or exploitation? And our guest today – Dr. Barry Eichengreen, Professor of Economic Studies at UC Berkley NEW! DOWNLOAD THIS EPISODE'S AI GENERATED SHOW NOTES (Guest Segment) Barry Eichengreen (George C. Pardee and Helen N. Pardee, Professor of Economics) is a distinguished professor of Economics and Political Science at the University of California, Berkeley, where he is the George C. Pardee & Helen N. Pardee Chair. A leading expert on the international monetary system and global finance, his research covers the history of global financial crises, the international monetary system, economic history, and the causes and consequences of populism. Dr. Eichengreen holds fellowships from several institutions, including the National Bureau of Economic Research and the American Academy of Arts and Sciences, and has previously served as a Senior Policy Advisor at the International Monetary Fund (IMF). Learn More at http://www.ibkr.com/funds Follow @andrewhorowitz Looking for style diversification? More information on the TDI Managed Growth Strategy - https://thedisciplinedinvestor.com/blog/tdi-strategy/ eNVESTOLOGY Info - https://envestology.com/ Stocks mentioned in this episode: (BTCUSD), (ORCL), (OKLO), (QQQ)
“This really is the full motivation for my having written the memoir. I want people to know what the process is like; not only what the process is like but what the feelings are that don't really make you think of psychoanalysis as a way of changing your life. We're just living and hoping that things will change without really taking account of the fact that we could be living better lives and in a better way. I began to think of the ways of the world and the wickedness in it. There's so many things that we do to keep us going - me and my aphrodisiacs, and I think other people doing other things just to divert them from the misery and unhappiness that they feel. I don't know how often that's looked at or discussed, so I hope the book does open that up a little bit.” Episode Description: We begin with Beverly's description of her early years of feeling lost and the consequent self-destructive patterns she replayed. Years of sensation-seeking led her to become "exhausted, limp, tarnished, and each time, more profoundly lost." She "landed on an analyst's couch in Little Venice, a section of London. I was paying for someone to recognize me. She did." Beverly shares her analytic journey with us and how vital her discovery of 'kindness' was, first from the outside and then from within. We discuss the early death of her father, her mother's depression and the devotion of her older brother. She closes with "Like life, psychoanalysis is a continuing process. It doesn't stop...issues crop up, new feelings arise...we better understand what those feelings are telling us, and how to make use of them in an environment we have been able to choose for ourselves. And so it goes…" Our Guest: Beverly Kolsky, MSW has worked as a psychotherapist for more than forty years both in America and in England. She trained as a psychoanalyst with the New York Institute for Psychoanalytic Self Psychology also and received training in London where she worked under the auspices of the Tavistock Clinic and the Institute of Marital Studies. Her work has been published in two journals: Mind Consiliums and Voices: Art and Science of Psychotherapy. She had two psychoanalytic experiences in two countries with analysts of two different orientations. Her motivation for writing the book as a memoir was to let others in the community know the transformative and enduring power of psychoanalysis. She was in private practice in Englewood, N.J. and now lives, mostly retired, in the northern Adirondacks. Recommended Readings: Jung, C.G. 1963. Memories, Dreams, Reflections. London: Collins and Routledge and Kegan Paul. Kohut, H. 1984. How Does Analysis Cure? Chicago: University of Chicago Press. Kolsky, B. 2015 Mind Consiliums 15(10), (1-10). Empathy and Secrecy: Discovering Suicide as a Form of Addiction." Kolsky, B. 2019 "The Ghost in You: Psychotherapy and Grief" (Voices: The Art and Science of Psychotherapy.) Paperback The American Academy of Psychotherapists. Kolsky, B. 2019 Voices: Journal of the American Academy of Psychotherapists. Vol 55 No 2 "To Be or Not To Be: A Patient's Search for the Lost Mother." Kuchuck, S. 2021. London: Confer Books. The Relational Revolution in Psychoanalysis and Psychotherapy. Confer Books. Malan, D, 1979. England. Butterworth & Co Ltd. Individual Psychotherapy and the Science of Psychodynamics. Taylor, K. 2002. U.S. Kevin Taylor M.D. Seduction of Suicide: Understanding and Recovering From Addiction to Suicide.
In this episode of Talking Sleep, host Dr. Seema Khosla sits down with Dr. Anita Shelgikar, current president of the American Academy of Sleep Medicine, neurologist, and sleep fellowship program director at the University of Michigan, for a transparent look at how the AASM makes critical decisions that shape the field of sleep medicine. Ever wondered how clinical practice guidelines are developed and why updates take so long? Dr. Shelgikar pulls back the curtain on the comprehensive process behind guideline creation, from topic selection to evidence review to final publication. She explains how the AASM prioritizes which guidelines need updating and how members can influence these decisions. The conversation addresses pressing concerns facing sleep medicine practitioners: the ongoing review of home sleep apnea testing codes, declining reimbursement rates, and the financial viability of sleep medicine practices. Dr. Shelgikar discusses the AASM's advocacy efforts, recent legislative wins and setbacks, and strategies for improving the value proposition of polysomnography in an evolving healthcare landscape. Looking toward the future, the discussion explores emerging trends including the potential for inpatient sleep medicine services, the shift toward chronic disease management models, and new technologies like acoustic stimulation. Dr. Shelgikar shares insights on how the field might evolve beyond its traditional testing-focused approach and adapt to changing reimbursement structures. The episode also demystifies AASM governance: How are committees formed and sunset? Why can't every volunteer serve? What happens during board meetings? Is board membership reserved for academics? Dr. Shelgikar provides practical guidance on how members can engage more meaningfully with the organization and influence its direction. Whether you're a longtime AASM member curious about organizational decision-making or a newer member seeking to understand how to get involved, this episode offers valuable transparency into the processes that shape sleep medicine policy and practice. Join us for this informative conversation that bridges organizational leadership with frontline clinical concerns in sleep medicine.
Local fine artist Pamela Wilde joins Rich—along with her husband, veteran and GI Joe restorer Scott Wilde—to talk about portraits that capture the “human moment,” her 120-portrait community project in Havre de Grace, and her “Boots on the Ground” series honoring veterans. They dive into technique (why oil is “forgiving”), teaching/learning, galleries and grants, plus a wild mid-recording tech glitch and Scott's eerie encounter at Bachelor's Grove. Guest Bio: Pamela Wilde is a Maryland-based representational oil painter known for community portrait projects (including Portraits of Havre de Grace) and veteran-honoring works like Boots on the Ground. Trained at the American Academy of Art, she exhibits across the region and participates in plein-air programs. Scott Wilde is a U.S. Army veteran and noted restorer of vintage talking GI Joe figures who travels nationally for shows; he also appears in Pamela's veteran-focused art stories. Main Topics: · Why oil is “forgiving” vs. watercolor; mediums (linseed, walnut, wax/gel, Gamsol)· The making of Portraits of Havre de Grace: 120 portraits in a year· Prints vs. originals, value, and longevity· Boots on the Ground: combat boots as storytelling objects for veterans· Galleries, grants, and exhibits (local to statewide; BWI, Gallery 220, etc.)· Teaching vs. lifelong learning; finding supportive instructors· Paranormal-tinged studio glitch + Scott's Bachelor's Grove story· Scott's niche: repairing vintage talking GI Joes; art as business & discipline· Advice to emerging artists: multitasking, perseverance, community· Plein-air work with Maryland Center for the Arts; upcoming Armory show· Favorite artists: John Singer Sargent (historic) and Rose Frandsen (living) Resources mentioned: · Pamela Wilde (artist) – “Portraits of Havre de Grace,” “Boots on the Ground” (contact via her website - https://pamelawilde.com/)· Scott Wilde – vintage talking GI Joe repairs (national show circuit)· Havre de Grace Arts Collective / Gallery (open studios, modeling)· Maryland State Arts Council (grant support)Send us a textPodMatchPodMatch Automatically Matches Ideal Podcast Guests and Hosts For InterviewsSupport the showRate & Review on Apple Podcasts Follow the Conversations with Rich Bennett podcast on Social Media:Facebook – Conversations with Rich Bennett Facebook Group (Join the conversation) – Conversations with Rich Bennett podcast group | FacebookTwitter – Conversations with Rich Bennett Instagram – @conversationswithrichbennettTikTok – CWRB (@conversationsrichbennett) | TikTok Sponsors, Affiliates, and ways we pay the bills:Hosted on BuzzsproutSquadCast Subscribe by Email
What does it really take to “disrupt divorce”? In this episode, Rhonda sits down with Jordan Rosenberg, a family law attorney from the Chicago area who believes the attorney–client relationship should be a true partnership — built on open communication, trust, and collaboration. Together, they pull back the curtain on what most attorneys wish their clients knew and how women can take a more empowered role in the process. You'll hear insights on: Why viewing your lawyer as a partner — not just a service provider — changes everything The power of organization (and how small clues, like a $5 savings account, can reveal much bigger financial issues) Why “the smartest people know when to ask for help” — and how that applies directly to divorce The importance of building the right team: legal, financial, and emotional support How to set realistic expectations — without slipping into worst-case-scenario thinking Why “trusting the process” doesn't mean handing over control, but staying actively engaged Jordan also shares one of his favorite quotes that perfectly fits this stage of life: FEAR = Forget Everything And Run, or Face Everything And Rise. This episode is packed with both practical tools and encouragement for anyone navigating the complexities of divorce.
When it comes to a child's backpack, 10% to 15% of body weight is the maximum safe range, according to the American Academy of Pediatrics (AAP). For example, a backpack that weighs 6.6 to 10 lbs. (3 to 4.5 kg) is recommended for a child weighing 66 pounds (30 kilograms) 5% to 10% of body weight is recommended for smaller children, those who have longer walks or commute, or if pain is already present Weigh, don't guess — use a bathroom scale to check. If the pack exceeds the range, remove items or split the load The way a backpack fits is just as important as its weight. Always use two straps, keep the pack high and snug, and place heavier items close to the spine Watch for warning signs that a backpack is too heavy, including leaning forward, red strap marks, tingling or numbness, or frequent complaints of back, neck, or shoulder pain
As a girl in England, Jane Goodall dreamed of traveling to Africa to study animals in the wild. In 1960, that dream brought her to Tanzania, to observe the wild chimpanzees at Gombe Stream Park. As she describes in this episode, other scientists did not believe that a young woman could survive alone in the bush, but Jane Goodall did more than survive. Her work revolutionized the field of primatology. She was the first to document chimpanzees making and using tools, an activity that had been thought exclusively humans. Over the years she also witnessed cooperative hunting and altruism, but also brutality and even warfare among chimps. Her work, the longest continuous field study of any living creature, has given us deep insights into the evolution of our own species. Since the 1980's, she has devoted herself single-mindedly to educating the public worldwide about the connections between animal welfare, the environment, and human progress. (c ) American Academy of Achievement 2017
"Chaos and confusion." That's what the head of the American Academy of Pediatrics says families are up against as the federal government rethinks established science for everything from vaccines to autism. Dr. Susan Kressly was recently in Colorado for the AAP's annual conference. Then, an effort to get girls interested in construction jobs. Plus, we visit "The Gathering Place" which elevates the southwest in the Colorado Springs Fine Arts Center. And, remembering renowned conservationist and researcher Dr. Jane Goodall with her visit to Colorado.
A funding lapse in Washington sets the stage, but the real story is how power, process, and language shape outcomes—from the Senate's 60‑vote math to a New Mexico special session that narrows what gets debated. We open by decoding the shutdown: why a seven‑week continuing resolution stalled, how polling and precedent drive the blame game, and why markets shrugged while politicians postured. Then we zoom into Santa Fe, where a fast‑tracked agenda centers on health policy—especially a quiet but consequential shift that would remove CDC ACIP as the reference for school immunization schedules and lean on the state health department and the American Academy of Pediatrics. We unpack what that means for scientific independence, conflicts of interest, and public trust, and make the case for more—not fewer—credible voices in the room.From statehouse to city hall, we tackle Albuquerque's sanctuary city status. Polling shows majority support when the policy is framed as non‑cooperation “except when required by law,” but a mayoral order adding a hotline to alert residents about ICE activity raises safety and operational concerns. We connect those dots to voters' top anxieties—crime and homelessness—and explore how perceptions of safety track party identity more than daily reality, complicating honest problem‑solving.Campaign sparks fly in the Democratic gubernatorial primary over policy authorship, reminding us that voters care less about who wrote a plan and more about who can deliver measurable results. The temperature spikes again when a state representative compares ICE to the KKK—rhetoric condemned by law enforcement and flagged here for what it is: reckless. We close with a practical bright spot—drug pricing reforms tied to most‑favored‑nation benchmarks and a “Trump RX” fallback that could drive substantial savings for Medicare, Medicaid, and consumers if implemented with transparency and competition in mind.If you value sharp analysis without the spin, follow the show, share this episode with a friend, and leave a quick review so more listeners can find it. Your feedback helps us tackle the next big story with more depth and clarity.Website: https://www.nodoubtaboutitpodcast.com/Twitter: @nodoubtpodcastFacebook: https://www.facebook.com/NoDoubtAboutItPod/Instagram: https://www.instagram.com/markronchettinm/?igshid=NTc4MTIwNjQ2YQ%3D%3D
Episode 51 - Clinicians Driving Interoperability: Insights from the HL7 Da Vinci Project Clinical Advisory Council (CAC) On this episode POCP CEO and host Tony Schueth sat down with Dr. Julia Skapik (SVP & CMO at PurpleLab, practicing physician, member of the HL7 Da Vinci Clinical Advisory Council, and outgoing HL7 International board chair) and Dr. Steven Waldron (Chief Medical Informatics Officer at the American Academy of Family Physicians and Co-Chair of the Da Vinci Clinical Advisory Council). Together, they explored how clinicians are shaping interoperability and standards development through the HL7 Da Vinci Project's Clinical Advisory Council (CAC).
In this episode, we're joined by Dr. Kelly McCann, MD, a trailblazer in functional, integrative, and environmental medicine. With over two decades of experience, Dr. Kelly has helped thousands of individuals achieve lasting wellness by addressing the root causes of their health concerns with personalized, compassionate care. Currently practicing at The Spring Center in Southern California, she is also an active board member for the American Academy of Environmental Medicine and the International Society of Environmentally Acquired Illness. Dr. Kelly blends conventional medicine with holistic practices, integrating the mind-body-spirit connection into every treatment plan. Her approach draws on acupuncture, herbal medicine, meditation, energy work, and more, providing comprehensive healing solutions for her patients. In this conversation, we explore: · How Dr. Kelly integrates holistic medicine into her healing methods. · Debunking common misconceptions about Lyme Disease and chronic inflammation. · The impact of chronic inflammation on cellular health. · The benefits of working with functional and integrative medicine practitioners for complex health issues. · How spiritual growth contributes to physical well-being and healing. From autoimmune diseases to hormone imbalances, Dr. Kelly's holistic approach addresses a wide range of conditions. Tune in to hear how her healing philosophy can transform your health! Interested in learning more or booking an appointment? Visit Dr. Kelly's website to explore her services. Episode also available on Apple Podcasts: https://apple.co/38oMlMr Keep up with Dr. Kelly McCann socials here: Facebook: https://www.facebook.com/drkellymccann/ Instagram: https://www.instagram.com/drkellymccann/?hl=en Youtube: https://www.youtube.com/@DrKellyMcCann
How do we help our neurodivergent kids feel confident in their own bodies? That's the big question in this week's episode of The Autism Dad Podcast. I'm joined by Dr. Whitney Casares, pediatrician, public health expert, autism mom, and fellow at the American Academy of Pediatrics, to talk about her new book My One of a Kind Body: The Ultimate Guide to Caring for Me. Dr. Casares opens up about raising her autistic and ADHD children, why body image hits differently for neurodivergent kids, and how parents can support healthy habits without shame or pressure. We talk about diet culture, social media, body bullies, and how to help kids see themselves as enough, exactly as they are. If you've ever worried about your child's self-esteem, eating struggles, or how to navigate tricky conversations about body changes, this episode will give you guidance, validation, and tools to move forward. • Why body image issues impact autistic and ADHD kids differently • How Dr. Casares' daughter inspired her new book • The lasting effects of diet culture on kids (and parents) • Helping neurodivergent kids navigate social media pressure • Practical ways to address sensory eating and movement challenges • Scripts and strategies parents can use when tough questions come up • Why BMI isn't the full picture of health for children • How to model body confidence while managing your own struggles Dr. Casares is a board-certified pediatrician and public health expert, and autism mom. She is a fellow at the American Academy of Pediatrics, host of The Modern Mommy Doc Podcast, and author of several books, including My One of a Kind Body. Her work helps parents raise confident, resilient kids while giving themselves grace along the way. Website: modernmommydoc.com Rob Gorski is the founder of The Autism Dad blog and host of The Autism Dad Podcast. A single father to three autistic children, Rob shares his family's journey to validate and support parents raising neurodivergent kids. His work has been featured by CNN, ABC News, BBC Worldwide, and more. Algonot: Check out NeuroProtek, a brain-supporting flavonoid supplement developed by a Yale-trained neuroinflammation expert. Save 5% with code ROB5 at algonot.com. Mightier: Help your child build emotional regulation skills through fun, game-based biofeedback. Save 10% with code theautismdad22 at mightier.com. If you found this episode helpful, please follow The Autism Dad Podcast on Apple Podcasts, Spotify, or wherever you listen. Visit listen.theautismdad.com for past episodes, resources, and ways to support the show.
In this episode of the HPNA Palliative Perspective Podcast, we welcome Doug Wubben, a health care professional with a diverse background in nursing and coaching. Doug brings extensive experience as an Oncology Case Manager and Goals of Care Educator, roles that have shaped his deep understanding of person-centered communication and interprofessional collaboration. Currently, he works as a Life & Leadership Coach, supporting clinicians as they navigate the personal and professional challenges of caregiving roles. In this episode, Doug shares insights from both his clinical practice and coaching work, offering a unique perspective on how we can address empathic distress, acknowledge and learn from a culture of mistakes, and build meaningful process improvements. He reminds us of the value in slowing down, making space to feel, and cultivating the most important compassion of them all—for ourselves. Doug Wubben, RN, BSN, PCC Doug Wubben, RN, BSN, PCC is a Life and Leadership Coach and High Reliability Specialist at the VA Hospital in Madison, WI. His career has been anything but linear—spanning roles as a caregiver, organic farmer, local food advocate, nurse, and now coach—giving him a rare lens on how humans grow through change and optimize life transitions. With 14 years in nursing and a deep commitment to end-of-life care, Doug has led countless goals-of-care conversations and trained hundreds of clinicians to approach them with clarity and compassion. Today, he's helping health care professionals turn their care inward—teaching them how tending to their own well-being unlocks deeper, more sustainable care for others. Brett Snodgrass, DNP, FNP-C, ACHPN®, FAANP Dr. Brett Snodgrass has been a registered nurse for 28 years and a Family Nurse Practitioner for 18 years, practicing in multiple settings, including family practice, urgent care, emergency departments, administration, chronic pain and palliative medicine. She is currently the Operations Director for Palliative Medicine at Baptist Health Systems in Memphis, TN. She is board certified with the American Academy of Nurse Practitioners. She is also a Fellow of the American Association of Nurse Practitioners and an Advanced Certified Hospice and Palliative Nurse. She completed a Doctorate of Nursing Practice at the University of Alabama – Huntsville. She is a nationally recognized nurse practitioner speaker and teacher. Brett is a chronic pain expert, working for more than 20 years with chronic pain and palliative patients in a variety of settings. She is honored to be the HPNA 2025 podcast host. She is married with two daughters, two son in laws, one grandson, and now an empty nest cat. She and her family are actively involved in their church and she is an avid reader.
Functional movement disorders are a common clinical concern for neurologists. The principle of “rule-in” diagnosis, which involves demonstrating the difference between voluntary and automatic movement, can be carried through to explanation, triage, and evidence-based multidisciplinary rehabilitation therapy. In this episode, Gordon Smith, MD, FAAN speaks Jon Stone, PhD, MB, ChB, FRCP, an author of the article “Multidisciplinary Treatment for Functional Movement Disorder” in the Continuum® August 2025 Movement Disorders issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Stone is a consultant neurologist and honorary professor of neurology at the Centre for Clinical Brain Sciences at the University of Edinburgh in Edinburgh, United Kingdom. Additional Resources Read the article: Multidisciplinary Treatment for Functional Movement Disorder Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @gordonsmithMD Guest: @jonstoneneuro Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. This exclusive Continuum Audio interview is available only to you, our subscribers. We hope you enjoy it. Thank you for listening. Dr Smith: Hello, this is Dr Gordon Smith. Today I've got the great pleasure of interviewing Dr Johnstone about his article on the multidisciplinary treatment for functional neurologic disorder, which he wrote with Dr Alan Carson. This article will appear in the August 2025 Continuum issue on movement disorders. I will say, Jon, that as a Continuum Audio interviewer, I usually take the interviews that come my way, and I'm happy about it. I learn something every time. They're all a lot of fun. But there have been two instances where I go out and actively seek to interview someone, and you are one of them. So, I'm super excited that they allowed me to talk with you today. For those of our listeners who understand or are familiar with FND, Dr Stone is a true luminary and a leader in this, both in clinical care and research. He's also a true humanist. And I have a bit of a bias here, but he was the first awardee of the Ted Burns Humanism in Neurology award, which is a real honor and reflective of your great work. So welcome to the podcast, Jon. Maybe you can introduce yourself to our audience. Dr Stone: Well, thank you so much, Gordon. It was such a pleasure to get that award, the Ted Burns Award, because Ted was such a great character. I think the spirit of his podcasts is seen in the spirit of these podcasts as well. So, I'm a neurologist in Edinburgh in Scotland. I'm from England originally. I'm very much a general neurologist still. I still work full-time. I do general neurology, acute neurology, and I do two FND clinics a week. I have a research group with Alan Carson, who you mentioned; a very clinical research group, and we've been doing that for about 25 years. Dr Smith: I really want to hear more about your clinical approach and how you run the clinic, but I wonder if it would be helpful for you to maybe provide a definition. What's the definition of a functional movement disorder? I mean, I think all of us see these patients, but it's actually nice to have a definition. Dr Stone: You know, that's one of the hardest things to do in any paper on FND. And I'm involved with the FND society, and we're trying to get together a definition. It's very hard to get an overarching definition. But from a movement disorder point of view, I think you're looking at a disorder where there is an impairment of voluntary movement, where you can demonstrate that there is an automatic movement, which is normal in the same movement. I mean, that's a very clumsy way of saying it. Ultimately, it's a disorder that's defined by the clinical features it has; a bit like saying, what is migraine? You know? Or, what is MS? You know, it's very hard to actually say that in a sentence. I think these are disorders of brain function at a very broad level, and particularly with FND disorders, of a sort of higher control of voluntary movement, I would say. Dr Smith: There's so many pearls in this article and others that you've written. One that I really like is that this isn't a diagnosis of exclusion, that this is an affirmative diagnosis that have clear diagnostic signs. And I wonder if you can talk a little bit about the diagnostic process, arriving at an FND diagnosis for a patient. Dr Stone: I think this is probably the most important sort of “switch-around” in the last fifteen, twenty years since I've been involved. It's not new information. You know, all of these diagnostic signs were well known in the 19th century; and in fact, many of them were described then as well. But they were kind of lost knowledge, so that by the time we got to the late nineties, this area---which was called conversion disorder then---it was written down. This is a diagnosis of exclusion that you make when you've ruled everything out. But in fact, we have lots of rule in signs, which I hope most listeners are familiar with. So, if you've got someone with a functional tremor, you would do a tremor entrainment test where you do rhythmic movements of your thumb and forefinger, ask the patient to copy them. It's very important that they copy you rather than make their own movements. And see if their tremor stops briefly, or perhaps entrains to the same rhythm that you're making, or perhaps they just can't make the movement. That might be one example. There's many examples for limb weakness and dystonia. There's a whole lot of stuff to learn there, basically, clinical skills. Dr Smith: You make a really interesting point early on in your article about the importance of the neurological assessment as part of the treatment of the patient. I wonder if you could talk to our listeners about that. Dr Stone: So, I think, you know, there's a perception that- certainly, there was a perception that that the neurologist is there to make a diagnosis. When I was training, the neurologist was there to tell the patient that they didn't have the kind of neurological problem and to go somewhere else. But in fact, that treatment process, when it goes well, I think begins from the moment you greet the patient in the waiting room, shake their hand, look at them. Things like asking the patient about all their symptoms, being the first doctor who's ever been interested in their, you know, horrendous exhaustion or their dizziness. You know, questions that many patients are aware that doctors often aren't very interested in. These are therapeutic opportunities, you know, as well as just taking the history that enable the patient to feel relaxed. They start thinking, oh, this person's actually interested in me. They're more likely to listen to what you've got to say if they get that feeling off you. So, I'd spend a lot of time going through physical symptoms. I go through time asking the patient what they do, and the patients will often tell you what they don't do. They say, I used to do this, I used to go running. Okay, you need to know that, but what do they actually do? Because that's such valuable information for their treatment plan. You know, they list a whole lot of TV shows that they really enjoy, they're probably not depressed. So that's kind of useful information. I also spend a lot of time talking to them about what they think is wrong. Be careful, that they can annoy patients, you know. Well, I've come to you because you're going to tell me what's wrong. But what sort of ideas had you had about what was wrong? I need to know so that I can deal with those ideas that you've had. Is there a particular reason that you're in my clinic today? Were you sent here? Was it your idea? Are there particular treatments that you think would really help you? These all set the scene for what's going to come later in terms of your explanation. And, more importantly, your triaging of the patient. Is this somebody where it's the right time to be embarking on treatment, which is a question we don't always ask yourself, I think. Dr Smith: That's a really great point and kind of segues to my next question, which is- you talked a little bit about this, right? Generally speaking, we have come up with this is a likely diagnosis earlier, midway through the encounter. And you talked a little bit about how to frame the encounter, knowing what's coming up. And then what's coming up is sharing with the patient our opinion. In your article, you point out this should be no different than telling someone they have Parkinson's disease, for instance. What pearls do you have and what pitfalls do you have in how to give the diagnosis? And, you know, a lot of us really weren't trained to do this. What's the right way, and what are the most common land mines that folks step on when they're trying to share this information with patients? Dr Stone: I've been thinking about this for a long time, and I've come to the conclusion that all we need to do with this disorder is stop being weird. What goes wrong? The main pitfall is that people think, oh God, this is FND, this is something a bit weird. It's in a different box to all of the other things and I have to do something weird. And people end up blurting out things like, well, your scan was normal or, you haven't got epilepsy or, you haven't got Parkinson's disease. That's not what you normally do. It's weird. What you normally do is you take a deep breath and you say, I'm sorry to tell you've got Parkinson's disease or, you have this type of dystonia. That's what you normally say. If you follow the normal- what goes wrong is that people don't follow the normal rules. The patient picks up on this. What's going on here? This doctor's telling me what I don't have and then they're starting to talk about some reason why I've got this, like stress, even though I don't- haven't been told what it is yet. You do the normal rules, give it a name, a name that you're comfortable with, preferably as specific as possible: functional tremor, functional dystonia. And then do what you normally do, which is explain to the patient why you think it's this. So, if someone's got Parkinson's, you say, I think you've got Parkinson's because I noticed that you're walking very slowly and you've got a tremor. And these are typical features of Parkinson. And so, you're talking about the features. This is where I think it's the most useful thing that you can do. And the thing that I do when it goes really well and it's gone badly somewhere else, the thing I probably do best, what was most useful, is showing the patient their signs. I don't know if you do that, Gordon, but it's maybe not something that we're used to doing. Dr Smith: Wait, maybe you can talk more about that, and maybe, perhaps, give an example? Talk about how that impacts treatment. I was really impressed about the approach to physical therapy, and treatment of patients really leverages the physical examination findings that we're all well-trained to look for. So maybe explore that a little bit. Dr Stone: Yeah, I think absolutely it does. And I think we've been evolving these thoughts over the last ten or fifteen years. But I started, you know, maybe about twenty years ago, started to show people their tremor entrainment tests. Or their Hoover sign, for example; if you don't know Hoover sign, weakness of hip extension, that comes back to normal when the person's flexing their normal leg, their normal hip. These are sort of diagnostic tricks that we had. Ahen I started writing articles about FND, various senior neurologists said to me, are you sure you should write this stuff down? Patients will find out. I wrote an article with Marc Edwards called “Trick or Treat in Neurology” about fifteen years ago to say that actually, although they're they might seem like tricks, there really are treats for patients because you're bringing the diagnosis into the clinic room. It's not about the normal scan. You can have FND and MS. It's not about the normal scan. It's about what you're seeing in front of you. If you show that patient, yes, you can't move your leg. The more you try, the worse it gets. I can see that. But look, lift up your other leg. Let me show you. Can you see now how strong your leg is? It's such a powerful way of communicating to the patient what's wrong with them diagnostically, giving them that confidence. What it's also doing is showing them the potential for improvement. It's giving them some hope, which they badly need. And, as we'll perhaps talk about, the physio treatment uses that as well because we have to use a different kind of physio for many forms of functional movement disorder, which relies on just glimpsing these little moments of normal function and promoting them, promoting the automatic movement, squashing down that abnormal pattern of voluntary movement that people have got with FND. Dr Smith: So, maybe we can talk about that now. You know, I've got a bunch of other questions to ask you about mechanism and stuff, but let's talk about the approach to physical therapy because it's such a good lead-in and I always worry that our physical therapists aren't knowledgeable about this. So, maybe some examples, you have some really great ones in the article. And then words of wisdom for us as we're engaging physical therapists who may not be familiar with FND, how to kind of build that competency and relationship with the therapist with whom you work. Dr Stone: Some of the stuff is the same. Some of the rehabilitation ideas are similar, thinking about boom and bust activity, which is very common in these patients, or grading activity. That's similar, but some of them are really different. So, if you have a patient with a stroke, the physiotherapist might be very used to getting that person to think and look at their leg to try and help them move, which is part of their rehabilitation. In FND, that makes things worse. That's what's happening in Hoover sign and tremor entrainment sign. Attention towards the limb is making it worse. But if the patient's on board with the diagnosis and understands it, they'll also see what you need to do, then, in the physio is actively use distraction in a very transparent way and say to the patient, look, I think if I get you to do that movement, and I'll film you, I think your movement's going to look better. Wouldn't that be great if we could demonstrate that? And the patient says, yeah, that would be great. We're kind of actively using distraction. We're doing things that would seem a bit strange for someone with other forms of movement disorder. So, the patients, for example, with functional gait disorders who you discover can jog quite well on a treadmill. In fact, that's another diagnostic test. Or they can walk backwards, or they can dance or pretend that they're ice skating, and they have much more fluid movements because their ice skating program in their brain is not corrupted, but their normal walking program is. So, can you then turn ice skating or jogging into normal walking? It's not that complicated, I think. The basic ideas are pretty simple, but it does require some creativity from whoever's doing the therapy because you have to use what the patient's into. So, if the patient used to be a dancer- we had a patient who was a, she was really into ballet dancing. Her ballet was great, but her walking was terrible. So, they used ballet to help her walk again. And that's incredibly satisfying for the therapist as well. So, if you have a therapist who's not sure, there are consensus recommendations. There are videos. One really good success often makes a therapist want to do that again and think, oh, that's interesting. I really helped that patient get better. Dr Smith: For a long time, this has been framed as a mental health issue, conversion disorder, and maybe we can talk a little bit about early life of trauma as a risk factor. But, you know, listening to you talk, it sounds like a brain network problem. Even the word “functional”, to me, it seems a little judgmental. I don't know if this is the best term, but is this really a network problem? Dr Stone: The word “functional”, for most neurologists, sounds judgmental because of what you associate it with. If you think about what the word actually is, it's- it does what it says on the tin. There's a disordered brain function. I mean, it's not a great word. It's the least worst term, in my view. And yes, of course it's a brain network problem, because what other organ is it going to be? You know, that's gone wrong? When software brains go wrong, they go wrong in networks. But I think we have to be careful not to swing that pendulum too far to the other side because the problem here, when we say asking the question, is this a mental health problem or a neurological one, we're just asking the wrong question. We're asking a question that makes no sense. However you try and answer that, you're going to get a stupid answer because the question doesn't make sense. We shouldn't have those categories. It's one organ. And what's so fascinating about FND---and I hope what can incite your sort of curiosity about it---is this disorder which defies this categorization. You see some patients with it, they say, oh, they've got a brain network disorder. Then you meet another patient who was sexually abused for five years by their uncle when they were nine, between nine and fourteen; they developed an incredibly strong dissociative threat response into that experience. They have crippling anxiety, PTSD, interpersonal problems, and their FND is sort of somehow a part of that; part of that experience that they've had. So, to ignore that or to deny or dismiss psychological, psychiatric aspects, is just as bad and just as much a mistake as to dismiss the kind of neurological aspects as well. Dr Smith: I wonder if this would be a good time to go back and talk a little bit about a concept that I found really interesting, and that is FND as a prodromal syndrome before a different neurological problem. So, for instance, FND prodromal to Parkinson's disease. Can you talk to us a little bit about that? I mean, obviously I was familiar with the fact that patients who have nonepileptic seizurelike events often have epileptic seizures, but the idea of FND ahead of Parkinson's was new to me. Dr Stone: So, this is definitely a thing that happens. It's interesting because previously, perhaps, if you saw someone who was referred with a functional tremor---this has happened to me and my colleagues. They send me some with a functional tremor. By the time I see them, it's obvious they've got Parkinson's because it's been a little gap. But it turns out that the diagnosis of functional tremor was wrong. It was just that they've developed that in the prodrome of Parkinson's disease. And if you think about it, it's what you'd expect, really, especially with Parkinson's disease. We know people develop anxiety in the prodrome of Parkinson's for ten, fifteen years before it's part of the prodrome. Anxiety is a very strong risk factor for FND, and they're already developing abnormalities in their brain predisposing them to tremor. So, you put those two things together, why wouldn't people get FND? It is interesting to think about how that's the opposite of seizures, because most people with comorbidity of functional seizures and epilepsy, 99% of the time the epilepsy came first. They had the experience of an epileptic seizure, which is frightening, which evokes strong threat response and has somehow then led to a recapitulation of that experience in a functional seizure. So yeah, it's really interesting how these disorders overlap. We're seeing something similar in early MS where, I think, there's a slight excess of functional symptoms; but as the disease progresses, they often become less, actually. Dr Smith: What is the prognosis with the types of physical therapy? And we haven't really talked about psychological therapy, but what's the success rate? And then what's the relapse rate or risk? Dr Stone: Well, it does depend who they're seeing, because I think---as you said---you're finding difficult to get people in your institution who you feel are comfortable with this. Well, that's a real problem. You know, you want your therapists to know about this condition, so that matters. But I think with a team with a multidisciplinary approach, which might include psychological therapy, physio, OT, I think the message is you can get really good outcomes. You don't want to oversell this to patients, because these treatments are not that good yet. You can get spectacular outcomes. And of course, people always show the videos of those. But in published studies, what you're seeing is that most studies of- case series of rehabilitation, people generally improve. And I think it's reasonable to say to a patient, that we have these treatments, there's a good chance it's going to help you. I can't guarantee it's going to help you. It's going to take a lot of work and this is something we have to do together. So, this is not something you're going to do to the patient, they're going to do it with you. Which is why it's so important to find out, hey, do they agree with you with the diagnosis? And check they do. And is it the right time? It's like when someone needs to lose weight or change any sort of behavior that they've just become ingrained. It's not easy to do. So, I don't know if that helps answer the question. Dr Smith: No, that's great. And you actually got right where I was wanting to go next, which is the idea of timing and acceptance. You brought this up earlier on, right? So, sometimes patients are excited and accepting of having an affirmative diagnosis, but sometimes there's some resistance. How do you manage the situation where you're making this diagnosis, but a patient's resistant to it? Maybe they're fixating on a different disease they think they have, or for whatever reason. How do you handle that in terms of initiating therapy of the overall diagnostic process? Dr Stone: We should, you know, respect people's rights to have whatever views they want about what's wrong with them. And I don't see my job as- I'm not there to change everyone's mind, but I think my job is to present the information to them in a kind of neutral way and say, look, here it is. This is what I think. My experience is, if you do that, most people are willing to listen. There are a few who are not, but most people are. And most of the time when it goes wrong, I have to say it's us and not the patients. But I think you do need to find out if they can have some hope. You can't do rehabilitation without hope, really. That's what you're looking for. I sometimes say to patients, where are you at with this? You know, I know this is a really hard thing to get your head around, you've never heard of it before. It's your own brain going wrong. I know that's weird. How much do you agree with it on a scale of naught to ten? Are you ten like completely agreeing, zero definitely don't? I might say, are you about a three? You know, just to make it easy for them to say, no, I really don't agree with you. Patients are often reluctant to tell you exactly what they're thinking. So, make it easy for them to disagree and then see where they're at. If they're about seven, say, that's good. But you know, it'd be great if you were nine or ten because this is going to be hard. It's painful and difficult, and you need to know that you're not damaging your body. Those sort of conversations are helpful. And even more importantly, is it the right time? Because again, if you explore that with people, if a single mother with four kids and, you know, huge debts and- you know, it's going to be very difficult for them to engage with rehab. So, you have to be realistic about whether it's the right time, too; but keep that hope going regardless. Dr Smith: So, Jon, there's so many things I want to talk to you about, but maybe rather than let me drive it, let me ask you, what's the most important thing that our listeners need to know that I haven't asked you about? Dr Stone: Oh God. I think when people come and visit me, they sometimes, let's go and see this guy who does a lot of FND, and surely, it'll be so easy for him, you know? And I think some of the feedback I've had from visitors is, it's been helpful to watch, to see that it's difficult for me too. You know, this is quite hard work. Patients have lots of things to talk about. Often you don't have enough time to do it in. It's a complicated scenario that you're unravelling. So, it's okay if you find it difficult work. Personally, I think it's very rewarding work, and it's worth doing. It's worth spending the time. I think you only need to have a few patients where they've improved. And sometimes that encounter with the neurologist made a huge difference. Think about whether that is worth it. You know, if you do that with five patients and one or two of them have that amazing, really good response, well, that's probably worth it. It's worth getting out of bed in the morning. I think reflecting on, is this something you want to do and put time and effort into, is worthwhile because I recognize it is challenging at times, and that's okay. Dr Smith: That's a great number needed to treat, five or six. Dr Stone: Exactly. I think it's probably less than that, but… Dr Smith: You're being conservative. Dr Stone: I think deliberately pessimistic; but I think it's more like two or three, yeah. Dr Smith: Let me ask one other question. There's so much more for our listeners in the article. This should be required reading, in my opinion. I think that of most Continuum, but this, I really truly mean it. But I think you've probably inspired a lot of listeners, right? What's the next step? We have a general or comprehensive neurologist working in a community practice who's inspired and wants to engage in the proactive care of the FND patients they see. What's the next step or advice you have for them as they embark on this? It strikes me, like- and I think you said this in the article, it's hard work and it's hard to do by yourself. So, what's the advice for someone to kind of get started? Dr Stone: Yeah, find some friends pretty quick. Though, yeah, your own enthusiasm can take you a long way, you know, especially with we've got much better resources than we have. But it can only take you so far. It's really particularly important, I think, to find somebody, a psychiatrist or psychologist, you can share patients with and have help with. In Edinburgh, that's been very important. I've done all this work with the neuropsychiatrist, Alan Carson. It might be difficult to do that, but just find someone, send them an easy patient, talk to them, teach them some of this stuff about how to manage FND. It turns out it's not that different to what they're already doing. You know, the management of functional seizures, for example, is- or episodic functional movement disorders is very close to managing panic disorder in terms of the principles. If you know a bit about that, you can encourage people around you. And then therapists just love seeing these patients. So, yeah, you can build up slowly, but don't- try not to do it all on your own, I would say. There's a risk of burnout there. Dr Smith: Well, Dr Stone, thank you. You don't disappoint. This has really been a fantastic conversation. I really very much appreciate it. Dr Stone: That's great, Gordon. Thanks so much for your time, yeah. Dr Smith: Well, listeners, again, today I've had the great pleasure of interviewing Dr Jon Stone about his article on the multidisciplinary treatment for functional neurologic disorder, which he wrote with Dr Alan Carson. This article appears in the August 2025 Continuum issue on movement disorders. Please be sure to check out Continuum Audio episodes from this and other issues. And listeners, thank you once again for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. We hope you've enjoyed this subscriber-exclusive interview. Thank you for listening.
Joe sits down with Julpohng “JP” Vilai, MD, Pediatrics Clerkship Director andAssistant Professor in the Department of Clinical Sciences at RosemanUniversity College of Medicine to talk about his journey into medicine and hisdeep commitment to community health in his hometown of Las Vegas. As VicePresident of the Nevada Chapter of the American Academy of Pediatrics and amember of the Gold Humanism Honor Society, Dr. Vilai shares how value-basedcare, humanism, and mentorship shape his work. He discusses hisleadership role at Roseman Medical Group, providing care to the underservedyouth at the Shannon West Homeless Youth Center, and his passion foradolescent, LGBTQIA+, and behavioral health. They also discuss theRoadrunner Visits and his dedication to training future physicians throughcompassionate, community-driven care.
California Passes Law Allowing State to Set Its Own Vaccine Guidance In a landmark move, California has passed a new law (AB 144, signed by Governor Gavin Newsom on September 17, 2025) that gives the state authority to establish its own vaccine schedules and related policies — rather than being bound by federal guidance from the Centers for Disease Control and Prevention (CDC). Here's a breakdown of what the law does, why it was enacted, and how it fits into a broader trend among U.S. states. Key Provisions of the Law Some of the main changes under AB 144: It establishes a baseline for vaccine coverage based on the Advisory Committee on Immunization Practices (ACIP) recommendations as of January 1, 2025. It authorizes the California Department of Public Health (CDPH) to modify or supplement those baseline recommendations, using guidance from independent medical organizations (like the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, etc.). It requires that state-regulated insurance plans (including Medi-Cal) cover vaccines that the state health department endorses under its guidance — meaning no copays for many Californians under those plans for state-recommended vaccines. It gives CA authority to act more independently of federal advisory bodies when those are perceived by state leadership to be compromised or less trustworthy. Why This Law Was Enacted Several reasons motivated the push for this law: Concerns over federal changes: The law reflects growing concern in California (and some other states) that recent shifts at the federal level — including reconstitution of advisory panels, changes in vaccine eligibility criteria, and what state officials view as politicization of public health — have undermined trust in the CDC's recommendations... Click Here or Click the link below for more details! https://naturallyrecoveringautism.com/230
Pedro e João discutem intoxicação por metanol, em meio ao surto de casos atual. Panorama do surto atual, outros casos no Brasil, sinais clínicos, diagnóstico e tratamento são abordados nesse episódio.Referências:1. https://methanolpoisoning.msf.org/wp-content/uploads/2023/03/MSF_International_Methanol-Poisoning_Protocol_v2_20230110_EN.pdf2. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/notas-tecnicas/2025/nota-tecnica-conjunta-no-360-2025-dvsat-svsa-ms.pdf3. Roberts, Darren M et al. “Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement.” Critical care medicine vol. 43,2 (2015): 461-72. doi:10.1097/CCM.00000000000007084. Kraut, Jeffrey A, and Michael E Mullins. “Toxic Alcohols.” The New England journal of medicine vol. 378,3 (2018): 270-280. doi:10.1056/NEJMra16152955. Kraut, Jeffrey A. “Approach to the Treatment of Methanol Intoxication.” American journal of kidney diseases : the official journal of the National Kidney Foundation vol. 68,1 (2016): 161-7. doi:10.1053/j.ajkd.2016.02.0586. Barceloux, Donald G et al. “American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning.” Journal of toxicology. Clinical toxicology vol. 40,4 (2002): 415-46. doi:10.1081/clt-1200067457. Souza FGT e, Nogueira VVE, Maynart LI, Oliveira RL de, Mendonça TC dos S, Oliveira PD. Neuropatia óptica tóxica por inalação de metanol. Rev brasoftalmol [Internet]. 2018Jan;77(1):47–9. Available from: https://doi.org/10.5935/0034-7280.201800108. https://www.gov.br/mj/pt-br/assuntos/noticias/nota-oficial-2014-governo-federal-estabelece-protocolo-de-acao-diante-de-intoxicacoes-por-metanol9. https://emcrit.org/ibcc/alcohols/10. Anyfantakis, D et al. “Ruling in the diagnosis of methanol intoxication in a young heavy drinker: a case report.” Journal of medicine and life vol. 5,3 (2012): 332-4.
The American Academy of Pediatrics (AAP) is heavily funded by pharmaceutical companies, influencing policies that promote more medical interventions for children while reducing parental control The AAP's top priority is to eliminate parental authority over childhood vaccination decisions, replacing it with state or provider control Major child health issues like rising obesity, increasing autism rates, and chronic illness prevention are absent from the AAP's top 10 priorities The AAP uses rare measles outbreaks to justify removing personal and religious vaccine exemptions, despite measles mortality already being near zero before mass vaccination began Ignoring preventive strategies, the AAP's approach sets children up for lifelong dependence on pharmaceutical products rather than building lasting health
Bruce Smith joins Kevin Young to read “Open Letter To My Ancestors” by Mary Ruefle, and his own poem “The Game.” Smith, the author of eight poetry collections, including the forthcoming “Hungry Ghost,” has received awards from the Academy of American Poets and the American Academy of Arts and Letters, in addition to fellowships from the Guggenheim Foundation and the National Endowment for the Arts. He teaches at Syracuse University. Learn about your ad choices: dovetail.prx.org/ad-choices
In this episode of Voices of Otolaryngology, host Rahul K. Shah, MD, MBA, AAO-HNS EVP and CEO, talks with Matthew D. Scarlett, MD, a private practice otolaryngologist in Charleston, South Carolina, and current Chair of the Academy's ENT Political Action Committee (PAC) Board. Dr. Scarlett breaks down how ENT PAC amplifies the voices of otolaryngologists on Capitol Hill, from securing meetings with lawmakers to advancing bills on prior authorization reform, Medicare reimbursement, and newborn CMV screening. Dr. Scarlett shares his personal journey into advocacy—sparked by frustration with barriers to patient care—and explains how ENT PAC strategically supports bipartisan lawmakers who can make a difference for physicians. The discussion highlights how the PAC Board prioritizes issues, the importance of member participation, and how easy actions like responding to “Act Now” alerts can significantly impact legislative outcomes. Whether you're a seasoned ENT or a trainee new to advocacy, this episode demystifies ENT PAC, encourages engagement, and shows how collective action strengthens the specialty's voice in Washington, DC. Resources: AAO-HNS Federal Legislative Advocacy: https://www.entnet.org/advocacy/federal-legislative-advocacy/ Project 535: https://myspecialty.entnet.org/AAOHNS/Project-535/Project-535.aspx Donate to the ENT PAC: https://donation.edonation.com/entpac/website/donate Note: Contributions to ENT PAC are not deductible as charitable contributions for federal income tax purposes. Contributions are voluntary, and all members of the American Academy of Otolaryngology–Head and Neck Surgery have the right to refuse to contribution without reprisal. Federal law prohibits ENT PAC from accepting contributions from foreign nationals. By law, if your contributions are made using a personal check or credit card, ENT PAC may use your contribution only to support candidates in federal elections. All corporate contributions to ENT PAC will be used for educational and administrative fees of ENT PAC, and other activities permissible under federal law. Federal law requires ENT PAC use its best efforts to collect and report the name, mailing address, occupation, and the name of the employer of individuals whose contributions exceed $200 in a calendar year. ENT PAC is a program of the AAO-HNS which is exempt from federal income tax under section 501 (c) (6) of the Internal Revenue Code.
Sign Up for My Free Live Webinar! Download my Free Guide 'In My Perimenopause Era' Ever walked down the supplement aisle and felt totally overwhelmed? Collagen powders, protein shakes, gummies, hair growth vitamins—where do you even start, and what actually works? In this episode, I sit down with Dr. Glynis Ablon to talk through all the ways nutrition and supplements can support our skin, hair, and overall health. She shares her evidence-based approach to building a healthy foundation, the supplements she trusts, and even her personal routine (yes, she really has bottles by the sink, bed, and fridge!). We cover everything from collagen, vitamin D, creatine, and bone density support in menopause, to hair supplements like Nutrafol and Viviscal, gut health, stress management, and the Standard American Diet (SAD). If you've ever wondered what supplements are worth your time, this episode is for you. Listen in, then share this conversation with a friend who's also navigating the supplement world. And don't forget to follow the show so you never miss an episode. Download the Free eBook 'Skincare Myths Busted' Key Takeaways: Why nutrition should always come first—and supplements should truly “supplement.” The best-studied supplements for skin, hair, nails, and healthy aging. Why collagen, vitamin D, and creatine are must-knows in midlife. Gut health, stress, and sleep as overlooked keys to glowing skin and strong hair. The truth about protein powders, sugar, raw dairy, and gummies. Which supplement brands Dr. Ablon actually trusts. Biohacking tools for longevity—what's hype vs. what's hopeful. Glynis Ablon, M.D., F.A.A.D., a native Californian, is a board-certified dermatologist with 27 years of experience, in medical, surgical, and aesthetic dermatology, completing her residency training at Baylor School of Medicine in Houston, Texas. Dr. Ablon is an Associate Clinical Professor at UCLA and a national investigator and educator for pharmaceutical companies. She is also the first published author in the United States in mesotherapy. She has published over 50 medical articles, two book chapters, and written three books. In addition, she is an on-camera medical consultant for The Doctors Show, ABC, CBS, NBC, KCAL, E! Entertainment, and Lifetime. She is a Fellow of the American Academy of Dermatology, American Academy of Liposuction Surgery, American Society for Laser Medicine and Surgery, and American Society for Dermatologic Surgery to name a few. Dr. Ablon also received the IMCAS Research Award 2010 for innovative research on Botulinum Toxins. Follow Glynis Ablon here: https://www.instagram.com/drablon/?hl=en https://abloninstitute.com/ The Skin Real app is officially LIVE! Download it now. Want more expert skin advice without the overwhelm? Subscribe to The Skin Real Podcast wherever you listen, and visit www.theskinreal.com for dermatologist-backed tips to help you feel confident in your skin—at every age. Follow Dr. Mina here:- https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin https://www.linkedin.com/in/drminaskin/ Visit Dr. Mina at Baucom & Mina Derm Surgery Website: atlantadermsurgery.com Email: scheduling@atlantadermsurgery.com Call: (404) 844-0496 Instagram: @baucomminamd Thanks for tuning in. And remember—real skin care is real simple when you know who to trust. Disclaimer: This podcast is for entertainment, educational, and informational purposes only and does not constitute medical advice.
Welcome to another episode of the Sustainable Clinical Medicine Podcast! In this episode, Dr. Sarah Smith sits down with Dr. Brittany Anderson, a passionate rural family medicine physician from Alabama who's breaking the myth that private practice is dead. Dr. Anderson shares her inspiring journey from employed, academic medicine—where bureaucracy and lack of autonomy led to burnout—to launching her own thriving private practice in 2022. She opens up about the challenges and rewards of creating a sustainable, patient-centered clinic from the ground up, how she built a strong team, and the financial realities of going solo. Dr. Anderson also offers valuable advice for physicians considering private practice, emphasizing the importance of vision, efficient teamwork, and maintaining personal well-being along the entrepreneurial journey. If you've ever wondered what it takes to make private practice work in today's healthcare landscape, or you're navigating burnout yourself, this episode is packed with practical insights, encouragement, and hope. Tune in and get ready to be inspired! Here are 3 key takeaways from this episode: Build on a Strong Foundation: Before launching your own practice, get crystal clear on your vision and mission. Let these guide every decision—from hiring to daily processes—so you create a practice aligned with your purpose. Teamwork & Efficiency Matter: Dr. Anderson credits her success to a well-integrated team. Investing in proper team formation, regular huddles, and empowering every staff member (from receptionist to nursing staff) leads to efficient care, happier patients, and less burnout. Start Lean, Grow Smart: You don't need the fanciest setup to begin. Focus on essential expenses, know your numbers, and market purposefully. Dr. Anderson started small, used powerful grassroots marketing, and filled her panel from day one—proof positive that strategic planning works! Meet Dr. Brittney Anderson: I'm Dr. Brittney Anderson, a board-certified family medicine physician and the founder and CEO of Anderson Family Care — a thriving private practice I launched in Alabama in 2022. I completed undergraduate studies at Duke University and medical school at UAB (Birmingham) I did my family medicine residency training at The University of Alabama (Tuscaloosa). I know firsthand how overwhelming (and exhilarating) it can be to step away from traditional models and create something of your own. That's why I'm passionate about helping other physicians reclaim their freedom and joy in medicine by launching successful private practices of their own. In addition to my clinical and coaching work, I host the podcast, Physicians Hanging a Shingle, and I'm honored to serve as current Board Chair of the Alabama Chapter of the American Academy of Family Physicians and Vice-Speaker for the Medical Association of the State of Alabama. I also serve on numerous boards throughout my community and state, working to amplify the voice of physicians and improve healthcare access in Alabama. You can find Dr. Brittney Anderson on: Instagram: @hanging_a_shingle Linked In: https://www.linkedin.com/in/drbrittneyanderson/ Website: https://hangingashingle.com/ Sign up for her weekly newsletter: https://hangingashingle.com/subscribe -------------- Would you like to view a transcript of this episode? Click Here **** Charting Champions is a premiere, lifetime access Physician only program that is helping Physicians get home with today's work done. All the proven tools, support and community you need to create time for your life outside of medicine. Learn more at https://www.chartingcoach.ca **** Enjoying this podcast? Please share it with someone who would benefit. Also, don't forget to hit “follow” so you get all the new episodes as soon as they are released. **** Come hang out with me on Facebook or Instagram. Follow me @chartingcoach to get more practical tools to help you create sustainable clinical medicine in your life. **** Questions? Comments? Want to share how this podcast has helped you? Shoot me an email at admin@reachcareercoaching.ca. I would love to hear from you.
Join leading experts Fariha Abbasi-Feinberg, MD, FAASM, Medical Director of Sleep Medicine at Millennium Physician Group and President Elect for the American Academy of Sleep Medicine; Inderpreet K. Madahar, MD, MBBS, Assistant Professor of Endocrinology, Diabetes, and Metabolism at Corewell Health; and Sarah Nadeem, MD, FACE, Assistant Professor, Section of Endocrinology, Diabetes, and Metabolism at Baylor College of Medicine, Houston, TX, as they discuss the complex relationship between obstructive and central sleep apnea and metabolic disorders such as obesity and type 2 diabetes.Key topics include:Who should be screened for sleep apnea and the recommended screening toolsFirst-line and adjunctive therapies for managementThe evolving role of multidisciplinary careHow clinical practice is shifting with the recent FDA label expansion of tirzepatide (Zepbound®)When tirzepatide may be considered alongside or in place of CPAP, APAP, and BiPAP therapiesTune in for practical insights to better identify, manage, and support patients at risk. This episode is made possible through a sponsorship from Lilly.
Trajectories of Fidgety Movements in Infants with and without medical complexity.This paper is a finalist for AACPDM's highest honour - the Gayle G Arnold award, chosen and highlighted by the scientific review committee for it's high quality.We look ahead at The American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) Conference - the 79th Annual Meeting!“Celebrating Resilience” October 15-18, 2025, to be held in New Orleans, LA.
Richard Tufton and Claire Mackenzie of the Six Inches of Soil Podcast generously shared with me a conversation they hosted between Gabe Brown and Dr. Temple Grandin. This is a fascinating conversation that covers Dr. Temple Grandin's perspective on regenerative agriculture and some of her solutions to the fragility in our food system. We get some great back and forth between Gabe and Dr. Grandin. Thanks again to Richard and Claire for sharing this conversation!Thanks to our Studio Sponsor, Understanding Ag!Head over to UnderstandingAg.com to book your consultation today!Sponsor:UnderstandingAg.comRelevant Links:Dr. Temple GrandinSubscribe to the Six Inches of Soil Podcast:Gabe Brown's Previous Episodes:Ep. 404 Gabe Brown and Dr. Allen Williams on Fixing America's Broken Rural EconomiesEp. 402 Gabe Brown and Dr. Allen Williams – Fixing America's Broken Water CycleEp. 380 Gabe Brown, Dr. Allen Williams, and Fernando Falomir – Soil Health Academy Q and AEp. 388 Gabe Brown and Luke Jones – Making the Regenerative ShiftEp. 361 Gabe Brown and Allen Williams – 2024 State of AgricultureEp. 305 Gabe Brown and Dr. Allen Williams – Matching Management to ContextEp. 293 Gabe Brown and Matt McGinn – Transitioning to More Adaptive StewardshipEp. 290 Gabe Brown and Dr. Allen Williams – Three Rules of Adaptive StewardshipEp. 288 Gabe Brown and Shane New – Managing the Nutrient CyleEp. 283 Gabe Brown and Dr. Allen Williams – The 6-3-4Ep. 281 Gabe Brown and Dr. Allen Williams – The State of Agriculture in North AmericaEp. 277 Gabe Brown – The State of the American Food SystemEp. 121 Gabe Brown – Heifer Development in Sync with NatureEp. 067 Gabe Brown – Dirt to SoilMore Info About Six Inches of Soil:Six Inches of Soil Podcast, Episode 8:Unbound: discovering unlimited potential when what's better for cattle is better for businessHost, producer: Richard TuftonCo-host, producer: Claire MackenzieSix Inches of Soil: Website: https://www.sixinchesofsoil.org/Book: https://www.sixinchesofsoil.org/bookInstagram: https://www.instagram.com/sixinchesofsoil/LinkedIn: https://www.linkedin.com/in/six-inches-of-soil-b75059234/Introduction:Dr Grandin and Gabe explore how uniting animal welfare with regenerative agriculture and combining soil practices with Temple's farming solutions, you have nature and nurture working together as one big metaphorical “hug machine”. This offers a communal hug, if you will, by enveloping the animal's life with a safe, healthy, happy and tranquil environment, which we know will undoubtedly provide a better life for them. Their conversations weave between regenerative agriculture, animal welfare, and consumer demand. The speakers discuss the importance of integrating livestock with crops, the challenges faced in modern agriculture, and the role of youth in shaping the future of farming. They emphasize the need for visual thinking and innovation in agricultural practices, as well as the impact of climate change on food production. Featuring: Dr Temple Grandin is an American scientist and industrial designer whose own experience with autism funded her professional work in creating systems to counter stress in certain human and animal populations.Dr. Grandin did not talk until she was three and a half years old. She was fortunate to get early speech therapy. Her teachers also taught her how to wait and take turns when playing board games. She was mainstreamed into a normal kindergarten at age five. Dr. Grandin became a prominent author and speaker on both autism and animal behavior. Today she is a professor of Animal Science at Colorado State University. She also has a successful career consulting on both livestock handling equipment design and animal welfare. She has been featured on NPR (National Public Radio) and a BBC Special – "The Woman Who Thinks Like a Cow". HBO made an Emmy Award winning movie about her life and she was inducted into the American Academy of Arts and Sciences in 2016.Gabe BrownGabe Brown is one of the pioneers of the current soil health movement which focuses on the regeneration of our resources. Gabe, along with his wife Shelly, and son Paul, ran Brown's Ranch, a diversified 5,000 acre farm and ranch near Bismarck, North Dakota. Their ranch focuses on farming and ranching in nature's image.They have now transitioned ownership of the ranch over to their son, Paul and his wife, Jazmin.Gabe authored the bestselling book, “Dirt to Soil, One Family's Journey Into Regenerative Agriculture.”Gabe is a partner and Board Member at Regenified and serves as the public face of the company. He is a founding partner in Understanding Ag, LLC.Websites: https://brownsranch.us/https://regenified.com/about-us/https://understandingag.com/partners/gabe-brown/Instagram: https://www.instagram.com/brownsranch/?hl=en
Just today in clinic, we had a patient, who was well into her third trimester, come to her regular scheduled appointment with new onset left-sided facial droop. Yeah, that's concerning! A complete history and physical was performed and the diagnosis was made of Bell's palsy. This is not a rare event and it can be extremely stressful for the affected mother to be because everybody knows facial droop is not normal! And we have recent data regarding this. In July 2025 in the Journal of Plastic, Reconstructive, and Aesthetic Surgery, authors confirmed that Bell's palsy can have real negative functional and psychosocial implications for those affected. So, in this episode, we are going to discuss Bell's palsy in pregnancy. How do we differentiate this from the more serious differential, which is a stroke? What about treatment? Listen in for details. 1. Wesley, Shaun R. MD; Vates, G. Edward MD, PhD; Thornburg, Loralei L. MD. Neurologic Emergencies in Pregnancy. Obstetrics & Gynecology 144(1):p 25-39, July 2024. | DOI: 10.1097/AOG.00000000000055752. Vrabec JT, Isaacson B, Van Hook JW. Bell's Palsy and Pregnancy.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2007;137(6):858-61. doi:10.1016/j.otohns.2007.09.009.3. Evangelista V, Gooding MS, Pereira L.Bell's Palsy in Pregnancy.Obstetrical & Gynecological Survey. 2019;74(11):674-678. doi:10.1097/OGX.00000000000007324. JPRAS (July 2025): https://www.jprasurg.com/article/S1748-6815(25)00328-6/fulltextSTRONG COFFEE PROMO: 20% Off Strong Coffee Company https://strongcoffeecompany.com/discount/CHAPANOSPINOBG
===== MDJ Script/ Top Stories for September 26th Publish Date: September 26th Commercial: From the BG AD Group Studio, Welcome to the Marietta Daily Journal Podcast. Today is Friday, September 26th and Happy Birthday to Tommy Lasorda I’m Keith Ippolito and here are the stories Cobb is talking about, presented by Times Journal Potential name changes on the horizon for Cobb Galleria, Performing Arts Centre Kennesaw to increase sanitation rates Health officials warn of measles in Georgia Plus, Leah McGrath from Ingles Markets on sodas All of this and more is coming up on the Marietta Daily Journal Podcast, and if you are looking for community news, we encourage you to listen and subscribe! BREAK: Ingles Markets 4 STORY 1: Potential name changes on the horizon for Cobb Galleria, Performing Arts Centre Big changes are coming to the Cobb Galleria Centre—and not just the $190 million renovation. A new name might be on the way, too. Charlie Beirne, the Galleria’s general manager, floated the idea of renaming it the “Cobb Convention Center” during a meeting Wednesday. “It’s simple, clear, and gives us national recognition,” he said. The authority’s board agreed, though Chair Jerry Nix admitted, “It’s not just a name change—there’s a lot of headache involved.” Meanwhile, the $145 million Cobb Energy Performing Arts Centre is also eyeing a rebrand, with naming rights expiring in 2027. A new sponsor could bring fresh funds to keep the venue cutting-edge. Renovations for both facilities are well underway, with the Galleria’s upgrades—including a grand entrance, expanded meeting spaces, and a sleek new look—set to wrap by early 2027. It’s the end of an era for the Galleria Specialty Shops, but Beirne says the revamped space will better serve the community and attract larger events. As for the Performing Arts Centre, a marketing firm has been hired to find a new name sponsor. Both projects signal a fresh chapter for these iconic Cobb landmarks. STORY 2: Kennesaw to increase sanitation rates Starting Nov. 1, Kennesaw residents will see a 6% bump in their sanitation rates. That means the standard monthly service—one trash can, one recycle cart—goes from $32.50 to $34.50. Got an extra trash can? That’ll now run you $19.50 a month, and additional recycle carts are $6. The increase hits December bills, but if you’ve prepaid for the year, you’re safe until your service period ends. Auto-pay users? Better update your payment info to dodge late fees. The city says it’s been eating rising costs for four years—18% higher, to be exact. “This adjustment was overdue,” Councilman Antonio Jones said, noting it was finalized with the 2026 budget. Republic Services, the city’s contractor, will continue handling trash, recycling, and yard waste. STORY 3: Health officials warn of measles in Georgia Georgia health officials are keeping a close eye on seven people who may have been exposed to measles after contact with infected individuals. On Tuesday, the state Department of Public Health confirmed three new cases, including one on Sept. 11. Two of the patients are unvaccinated, and the third? Their vaccination status is unclear. All three are isolating at home. So far, 268 close contacts have been identified, but only seven are under “active” monitoring. Officials stress vaccination is the best defense—kids should get their first dose between 12-15 months and a second by age 6. This year, Georgia has seen 10 measles cases, up from six last year. Nationwide, cases have been climbing since the pandemic disrupted routine vaccinations. Meanwhile, a CDC advisory panel recently stirred controversy by recommending standalone chickenpox vaccines for toddlers instead of the combined MMRV shot. The American Academy of Pediatrics pushed back, calling the move “misguided” and warning it could erode trust in vaccines. Georgia parents are urged to talk to their doctors about the best options for their kids. We have opportunities for sponsors to get great engagement on these shows. Call 770.799.6810 for more info. We’ll be right back. Break: Ingles Markets 4 STORY 4: New art exhibits in Marietta blend the personal, political and the abstract Two new exhibits are turning heads at the Marietta Cobb Museum of Art, running through Dec. 14: Craig Drennen’s “T is for Timon” and Ahmad Hassan Taylor’s “History Lessons.” Drennen, a Guggenheim fellow and Georgia State professor, spent 17 years crafting his Shakespeare-inspired collection. “Timon of Athens,” a play Shakespeare himself never staged, serves as his muse. “It’s a bad play by a great playwright,” Drennen quipped. “I use bad things to make good things.” His bold, abstract works—painted to mimic collages—are designed to last centuries. Taylor, known as the “Atlanta Illustrator,” makes his debut with striking cityscapes and politically charged pieces. One standout, “All In Favor (Of Hate),” features a white horse surrounded by biting commentary on perception and truth. Both artists will host free talks—Drennen on Nov. 1, Taylor on Dec. 14. Admission is free on Oct. 5, Nov. 2, and Dec. 7. STORY 5: Cobb extends student housing moratorium Cobb County’s moratorium on student housing applications just got another six-month extension, as officials wait for Kennesaw State University to wrap up its housing study. The Board of Commissioners voted unanimously Tuesday—no debate, just a quick vote—to keep the pause in place until spring 2026. This is the second extension since the ban started in October 2024. Community Development Director Jessica Guinn said it’ll likely be the last. The issue? It’s messy. Commissioner Keli Gambrill isn’t a fan of purpose-built student housing, saying KSU should handle its own housing needs. Chair Lisa Cupid, on the other hand, has pointed out that many students can’t find affordable housing because of county rules limiting unrelated people from living together. Meanwhile, not everyone’s on board with the moratorium. During public comment, Donald Barth didn’t hold back. “Have y’all bumped your heads?” he asked. “We need student housing. It brings growth, tax dollars, and no problems—at least not where I live.” The county plans to revisit the issue once KSU’s study is done, with potential updates to the student housing code included in the new Unified Development Code. And now here is Leah McGrath from Ingles Markets on sodas We’ll have closing comments after this. Break: Ingles Markets 4 Signoff- Thanks again for hanging out with us on today’s Marietta Daily Journal Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at mdjonline.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.
Duncan MacKenzie and Ryan Peter Miller drive up to the Dunn Museum in Libertyville, IL to talk with legendary comics painter Alex Ross. Known for Marvels, Kingdom Come, and decades of redefining superhero realism, Ross reflects on his career trajectory, his education at the American Academy of Art, his influences (from Neal Adams to Dave McKean), his early breaks with Now Comics and Leo Burnett storyboarding, and his transition into large-scale mural projects for Marvel and DC. The conversation ranges from comics history, realism in superhero depictions, variant cover economics, the physicality of superheroes, to America's appetite for dystopian narratives versus a return to the “pure Superman.” Ross is candid, funny, and deeply reflective about the comics medium, painting, and storytelling. Name-Drop List Artists & Writers Alex Ross — https://www.alexrossart.com/ | @alexrossart Neal Adams – https://nealadams.com/ George Pérez – https://www.tcj.com/george-perez-1954-2022/ Jack Kirby – https://kirbymuseum.org/ Dave McKean – https://www.davemckean.com/ Neil Gaiman — neilgaiman.com | @neilhimself Chris Ware – https://art21.org/artist/chris-ware/ Jim Lee — https://www.dc.com/talent/jim-lee @jimlee Todd McFarlane — https://mcfarlane.com/ @toddmcfarlane Erik Larsen — https://imagecomics.com/creators/erik-larsen @eriklarsen1138 John Tobias (Mortal Kombat) – https://www.mobygames.com/person/3326/john-tobias/ Tim Bradstreet — https://www.splashpageart.com/artistgalleryroom.asp?artistid=83 @timbradstreet Frank Casey (Ross's Superman model) – chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://news.wttw.com/sites/default/files/article/file-attachments/The%20process_Ross%20at%20work.pdf Institutions & Companies Dunn Museum (Libertyville, IL) — https://www.lcfpd.org/museum/ @lcfpd Marvel Comics — marvel.com | @marvel DC Comics — dc.com | @dccomics American Academy of Art (Chicago) — Leo Burnett (advertising) – https://dev.leoburnett.com/ Now Comics (Chicago, defunct) Eclipse Comics (defunct) FASA (publisher of Shadowrun, BattleTech) – https://shop.fasagames.com/index.php?main_page=index&cPath=68 Mortal Kombat franchise — https://www.mortalkombat.com/en-us @mortalkombat Pop Culture References Kingdom Come (DC) – https://en.wikipedia.org/wiki/Kingdom_Come_(comics) Marvels (Marvel) – https://tv.apple.com/us/movie/the-marvels/umc.cmc.6nb1ii3n99o7rewjyq8whcsuu Shadowrun RPG – https://store.catalystgamelabs.com/collections/shadowrun Vampire: The Masquerade (White Wolf) – https://en.wikipedia.org/wiki/Vampire:_The_Masquerade The Boys (Amazon Prime) – https://www.primevideo.com/detail/The-Boys/0KRGHGZCHKS920ZQGY5LBRF7MA Invincible (Image Comics / Amazon) – https://www.amazon.com/INVINCIBLE-SEASON-1/dp/B08WJN83XZ Peacemaker (HBO) – https://www.hbomax.com/shows/peacemaker-2022/a939d96b-7ffb-4481-96f6-472838d104ca Brightburn (film) – https://tv.apple.com/us/movie/brightburn/umc.cmc.4pkvqa1b6mf30wtx66vor37fq Image: John Weinstein
This member-driven podcast is a benefit of membership of the Arizona Chapter of the American Academy of Pediatrics (AzAAP) and is intended for AzAAP pediatric healthcare members.AzAAP would like to acknowledge the generous support of the podcast by the Arizona Department of Health Services through the Title V Maternal and Child Health Services Block Grant funding. No information or content in this podcast is intended to substitute or replace a consultation with a healthcare provider or specialist. All non-healthcare providers should reach out to their child's pediatrician for guidance. Music: Wallpaper by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/4604-wallpaperLicense: http://creativecommons.org/licenses/by/4.0/
Earlier this week, President Trump and his Administration made claims about the correlation between autism and Tylenol or acetaminophen use during pregnancy, warning pregnant women not to use the drug. A mounting backlash has followed with medical and autism experts alike disagreeing with Trump's claims. The American College of Obstetricians and Gynecologists and the American Academy of Pediatrics continue to recommend acetaminophen in pregnancy and childhood when used at the lowest dose for the shortest duration. Mayo Clinic trained Rheumatologist Dr. Alfred Miller takes aim with the claims and believes the Trump Admin. is ignoring scientific studies regarding autism. Dr. Miller joined us to discuss.
Earlier this week, President Trump and his Administration made claims about the correlation between autism and Tylenol or acetaminophen use during pregnancy, warning pregnant women not to use the drug. A mounting backlash has followed with medical and autism experts alike disagreeing with Trump's claims. The American College of Obstetricians and Gynecologists and the American Academy of Pediatrics continue to recommend acetaminophen in pregnancy and childhood when used at the lowest dose for the shortest duration.
In this episode of the Broad Street Review podcast, host Darnelle Radford engages with Anna Snapp, a performer at the Philadelphia Fringe Festival, discussing her production 'I Found the Sun Will Rise Tomorrow.' They explore Anna's artistic journey, the evolution of her work, and the healing power of performance. The conversation delves into the importance of audience engagement, the role of direction in theater, and the personal growth Anna has experienced through her art. The episode highlights the significance of self-discovery and the necessity of checking in with oneself amidst the hustle of life.Chapters00:00 Exploring the Philadelphia Fringe Festival02:04 Anna Snapp's Artistic Journey04:05 The Evolution of 'I Found the Sun Will Rise Tomorrow'08:30 The Impact of Performance on Healing14:20 Shifting Perspectives: From Victimhood to Empowerment18:42 The Role of Direction in Artistic Expression22:00 Engaging with the Audience: The Emotional Connection27:32 Self-Discovery Through Art32:54 The Importance of Checking In with OneselfI FOUND THAT the SUN WILL RISE TOMORROWAnna Snapp boldly shares the deeply personal, painful, and earth-shattering details of her long-term battle with chronic disease, mental illness, and sexual trauma in “one of the bravest performances [I] have seen in a long time.” (“I Found That the Sun Will Rise Tomorrow is a Brave Emotional Rollercoaster” - All About Solo). Snapp takes the audience through her atypical and agonizing coming-of-age story through the lens of being a young woman who was forced to put a terrifying puzzle together without the picture on the front of the box.About the ArtistAnna Snapp is a Philly-based actor, writer, and content creator whose work has been seen at festivals and companies including but not limited to the Edinburgh Fringe Festival, Off-Broadway on Theatre Row at The United Solo Theatre Festival, the Capital Fringe in Washington, D.C., New York Shakespeare Exchange, The Brick Theater, Irish Heritage Theatre, Blunt Ensemble, and Rising Sun Performance Company, and various medical establishments nationwide. She studied at The American Academy of Dramatic Arts in New York, Temple University, and at the London Academy of Music and Dramatic Art. She has a deep passion for creating art for social change, eliminating stigma surrounding mental illness, and transforming the healthcare system from within through the telling of her experiences with health crises that changed her life forever.FOR MORE INFORMATION: https://phillyfringe.org/events/i-found-that-the-sun-will-rise-tomorrow/
Dr. Anthea Mazzawi joins host Dr. Joel Berg to share her story as a dual pediatric dentist and orthodontist, a practice-owner and a mother. She delves into how the multifaceted roles have shaped her as a professional and leader, especially the opportunities to foster a network of peer experts. Dr. Mazzawi emphasizes the importance of a willingness to learn and Guest Bio: Dr. Anthea Mazzawi is a board-certified pediatric dentist who has practiced dentistry for almost 20 years. Raised along the gulf coast of Florida, she earned a B.S. degree in Developmental Biology from Florida State University and a D.M.D. degree from the University of Florida College of Dentistry. She then completed a residency in pediatric dentistry at the Medical University of South Carolina. She is currently in private practice with her husband, Dr. Miles Mazzawi, who is also a pediatric dentist. Their practice, Cherokee Children's Dentistry, has been serving the needs of children in the greater Atlanta area since 2007. Mazzawi is passionate about working with children and serving as an advocate for all child related issues. Mazzawi has been heavily involved with the American Academy of Pediatric Dentistry and organized dentistry throughout her career. She served as the president of The College of Diplomates of the American Board of Pediatric Dentistry in 2018 and has also been a part of several committees and councils for the American Academy of Pediatric Dentistry. Currently, she is the chairman of the Scientific Program Committee for the Annual Session. She also serves chairman of the Greater Atlanta Dental Foundation Gala Committee (an event that raises funds to meet the needs of several free/reduced fee clinics in Atlanta), and the secretary for the GA Academy of Pediatric Dentistry. Mazzawi is excited to serve as a trustee on the board of trustees for the AAPD. She looks forward to working with her colleagues, specifically the federal service membership, to promote for our profession and advance optimal oral health for all children. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode of the Look Forward Podcast, host Andy Critchlow is join by Stephen Smith of the American Academy of Actuaries to explore the intricate relationship between the AAA and the National Association of Insurance Commissioners (NAIC), and the modeling techniques used to assess risk in the actuarial landscape and how the industry is preparing for future challenges. For more content, please register for our upcoming webinar; "Recent NAIC Developments Relating to Insurer Fixed-Income Investments" The NAIC held its Summer National Meeting from August 10-13, and the NAIC Risk-Based Capital Investment Risk and Evaluation (E) Working Group held an interim meeting on September 8 to discuss the RBC treatment of CLOs. Join us for a dialogue with Larry Hamilton of Mayer Brown to discuss the latest news on CLOs and key investment-related developments from the Summer National Meeting.
Dr. Edmund Tsui sits down with Drs. Akshay S. Thomas and Ogul E. Uner to discuss their IRIS Registry study of the prevalence, characteristics, and treatment patterns of pediatric noninfectious uveitis in the United States. From their Ophthalmology Retina article, “Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry Analysis” Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry Analysis. Uner, Ogul E. et al. Ophthalmology Retina. In press. You love learning, which is why you listen to this podcast. Get live pearls and even more insights from top speakers from around the world at AAO 2025, the largest ophthalmology meeting in the world! Register now and get ready for Orlando at aao.org/RegNow. Ophthalmology journal events at AAO 2025: Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Emily Schehlein and Dr. Aaki Shukla, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Ophthalmology's Editor-in-Chief, Dr. Russell Van Gelder, as he presents the top Ophthalmology articles on Sunday October 19 at 9:45am. Search “SYM31” in the Mobile Meeting Guide for more information. Meet the Editor: Join us for an intimate conversation with Ophthalmology Editor-in-Chief, Dr. Russ Van Gelder, during the American Academy of Ophthalmology Annual Meeting. This special meet and greet offers ophthalmologists, residents, and researchers a unique chance to connect directly with one of our field's most influential editorial voices. Sunday, October 19, 3:30-4:30 pm, Academy Hub at the exhibit hall.
The federal government's approach to public health has changed more in the last eight months than it has in decades. Since President Trump returned to office, he and members of his administration have challenged the safety of the covid vaccine, the overall childhood vaccine schedule, and the causes of autism.This has upended public health guidance that doctors and patients have relied on for years. Jen Brull, the President of the American Academy of Family Physicians talks about how doctors and patients are navigating this moment.For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org.This episode was produced by Elena Burnett, Brianna Scott, and Megan Lim, with audio engineering by Hannah Gluvna.It was edited by Courtney Dorning.Our executive producer is Sami Yenigun.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
Dr. Patricia Tan serves as Medical Director for Rusk Pediatrics Rehabilitation. Her Certification is from the American Board of Physical Medicine & Rehabilitation. She has been selected as a Fellow by the following organizations: American Academy of Physical Medicine and Rehabilitation; American Academy of Pediatrics; American Academy of Cerebral Palsy and Developmental Medicine; and the Association of Academic Physiatrists. Her medical degree is from the University of Santo Tomas in Manila, Philippines. Dr. Megan Conklin is Associate Director of Rusk Pediatric Therapy Services at NYU Langone. She works collaboratively with an interdisciplinary team across the spectrum of pediatric diagnoses from birth through the transition into adulthood. She has a Doctor of Physical Therapy degree, 20 years of clinical experience at NYU; and is certified as a clinical specialist in pediatric physical therapy by the American Board of Physical Therapy Specialties of the American Physical Therapy Association. Part 1 The discussion included the following topics: kinds of health problems and conditions treated; age range of patients; clinical guidelines and evidence-based treatment protocols used; holistic approaches to treatment; collaboration with families of patients; and composition of the health care team
The CDC's advisory panel voted to recommend separate MMR and varicella shots for children under four, citing a slight seizure risk with the combined MMRV vaccine, a move strongly opposed by the American Academy of Pediatrics as misleading and confusing. In obesity care, a phase 3 trial showed oral semaglutide 25 mg led to an average 13.6% weight loss in adults without diabetes, reinforcing GLP-1 pills as an effective option. Meanwhile, a large study linked pediatric CT scan radiation to increased blood cancer risk, urging dose minimization and safer alternatives.
Is that penicillin or amoxicillin allergy real? Probably not. In this episode, we explore how to assess risk, talk to parents, and refer for delabeling. You'll also learn what happens in the allergy clinic, why the label matters, and how to be a better antimicrobial steward. Learning Objectives Describe the mechanisms and clinical manifestations of immediate and delayed hypersensitivity reactions to penicillin, including diagnostic criteria and risk stratification tools such as the PEN-FAST score. Differentiate between low-, moderate-, and high-risk penicillin allergy histories in pediatric patients and identify appropriate candidates for direct oral challenge or allergy referral based on current evidence and guidelines. Formulate an evidence-based approach for evaluating and counseling families in the Emergency Department about reported penicillin allergies, including when to recommend outpatient referral for formal delabeling. Connect with Brad Sobolewski PEMBlog: PEMBlog.com Blue Sky: @bradsobo X (Twitter): @PEMTweets Instagram: Brad Sobolewski References Khan DA, Banerji A, Blumenthal KG, et al. Drug Allergy: A 2022 Practice Parameter Update. J Allergy Clin Immunol. 2022;150(6):1333-1393. doi:10.1016/j.jaci.2022.08.028 Moral L, Toral T, Muñoz C, et al. Direct Oral Challenge for Immediate and Non-Immediate Beta-Lactam Allergy in Children. Pediatr Allergy Immunol. 2024;35(3):e14096. doi:10.1111/pai.14096 Castells M, Khan DA, Phillips EJ. Penicillin Allergy. N Engl J Med. 2019;381(24):2338-2351. doi:10.1056/NEJMra1807761 Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and Management of Penicillin Allergy: A Review.JAMA. 2019;321(2):188–199. doi:10.1001/jama.2018.19283 Transcript Note: This transcript was partially completed with the use of the Descript AI and the Chat GPT 5 AI Welcome to PEM Currents, the Pediatric Emergency Medicine podcast. As always, I'm your host, Brad Sobolewski, and today we are taking on a label that's misleading, persistent. Far too common penicillin allergy, it's often based on incomplete or inaccurate information, and it may end up limiting safe and effective treatment, especially for the kids that we see in the emergency department. I think you've all seen a patient where you're like. I don't think this kid's really allergic to amoxicillin, but what do you do about it? In this episode, we're gonna break down the evidence, walk through what actually happens during de labeling and dedicated allergy clinics. Highlight some validated tools like the pen FAST score, which I'd never heard of before. Preparing for this episode and discuss the current and future role of ED based penicillin allergy testing. Okay, so about 10% of patients carry a penicillin allergy label, but more than 90% are not truly allergic. And this label can be really problematic in kids. It limits first line treatment choices like amoxicillin, otitis media, or penicillin for strep throat, and instead. Kids get prescribed second line agents that are less effective, broader spectrum, maybe more toxic or poorly tolerated and associated with a higher risk of antimicrobial resistance. So it's not just an EMR checkbox, it's a label with some real clinical consequences. And it's one, we have a role in removing. And so let's understand what allergy really means. And most patients with a reported penicillin allergy, especially kids, aren't true allergies in the immunologic sense. Common misinterpretations include a delayed rash, a maculopapular, or viral exum, or benign, delayed hypersensitivity, side effects, nausea, vomiting, and diarrhea. And unverified childhood reactions that are undocumented and nonspecific. Most of these are not true allergies. Only a very small subset of patients actually have IgE mediated hypersensitivity, such as urticaria, angioedema, wheezing, and anaphylaxis. These are super rare, and even then they may resolve over time without treatment. If a parent or sibling has a history of a penicillin allergy, remember that patient might actually not be allergic, and that is certainly not a reason to label a child as allergic just because one of their first degree relatives has an allergy. So right now, in 2025, as I'm recording this episode, there are clinics like the Pats Clinic or the Penicillin Allergy Testing Services at Cincinnati Children's and in a lot of our peer institutions that are at the forefront of modern de labeling. Their approach reflects the standard of care as outlined by the. Quad ai or the American Academy of Allergy, asthma and Immunology and supported by large trials like Palace. And you know, you have a great trial if you have a great acronym. So here's what happens step by step. So first you stratify the risk. How likely is this to be a true allergy? And that's where a tool like the pen fast comes. And so pen fast scores, a decision rule developed to help assess the likelihood of a true penicillin allergy based on the patient's history. The pen in pen fast is whether or not the patient has a self-reported history of penicillin allergy. They get two points if the reaction occurred in the past five years. Two points if the reaction is anaphylaxis or angioedema. One point if the reaction required treatment, and one point if the reaction was not due to testing. And so you can get a total score of. Up to six points. If you have a score of less than three. This is a low risk patient and they can be eligible for direct oral challenge. A score greater than three means they're higher risk and they may require skin testing. First validation studies show that the PEN FFA score of less than three had a negative predictive value of 96.3%. Meaning a very, very low chance of a true allergy. And this tool has been studied more extensively in adults, but pediatric specific adaptations are emerging, and they do inform current allergy clinic protocols. But I would not use this score in the emergency department just to give a kid a dose of amoxicillin. So. For low risk patients, a pen fast score of less than three or equivalent clinical judgment clinics proceed with direct oral challenge with no skin testing required. The protocol is they administer one dose of oral amoxicillin and they observe for 62 120 minutes monitoring for signs of reaction Urticaria. Respiratory symptoms or GI upset. This approach is safe and effective. There was a trial called Palace back in 2022, which validated this in over 300 children. In adolescents. There were no serious events that occurred. De labeling was successful in greater than 95% of patients. And skin tested added no benefit in low risk patients. So if the child tolerates this dose, then you can remove that allergy immediately from the chart. Parents and primary care doctors will receive a summary letter noting that the challenge was successful and that there's new guidance. Children and families are told they can safely receive all penicillins going forward. And providers are encouraged to document this clearly in the allergy section of the EMR. So you're wondering, can we actually do this in the emergency department? Technically, yes, you can do what you want, but practically we're not quite there yet. So we'd need clearer risk stratification tools like the Pen fast, a safe place for monitoring, post challenge, clinical pathways and documentation support. You know, a clear way to update EMR allergy labels across the board and involvement or allergy or infectious disease oversight. But it's pretty enticing, right? See a kid you diagnose otitis media. You think that their penicillin allergy is wrong, you just give 'em a dose of amox and watch 'em for an hour. That seems like a pretty cool thing that we might be able to do. So some centers, especially in Canada and Australia, do have some protocols for ED or inpatient based de labeling, but they rely on that structured implementation. So until then, our role in the pediatric emergency department is to identify low risk patients, avoid over document. Unconfirmed reactions and refer to allergy ideally to a clinic like the pets. So who should be referred and good candidates Include a child with a rash only, especially one that's remote over a year ago. Isolated GI symptoms. Parents unsure of the details at all. No history of anaphylaxis wheezing her hives, and no recent serious cutaneous reactions. I would avoid referring and presume that this allergy is true. If they've had recent anaphylaxis, they've had something like Stevens Johnson syndrome dress, or toxic epidermolysis necrosis. Fortunately, those are very, very rare with penicillins and there's a need for penicillin during the ED visit without allergy backup. So even though we don't have an ED based protocol yet. De labeling amoxicillin or penicillin allergy can start with good questions in the emergency department. So here's one way to talk to patients and families. You can say, thanks for letting me know about the amoxicillin allergy. Can I ask you a few questions to better understand what happened? This is gonna help us decide the safest and most effective treatment for your child today, and then possibly go through a process to remove a label for this allergy that might not be accurate. You wanna ask good, open-ended questions. What exactly happened when your child took penicillin or amoxicillin? You know, look for rash, hives, swelling, trouble breathing, or anaphylaxis. Many families just say, allergic, when the reaction was just GI upset, diarrhea or vomiting, which is not an allergy. How old was your child when this happened? Reactions that occurred before age of three are more likely to be falsely attributed. How soon after taking the medicine did the reaction start? Less than one hour is an immediate reaction, but one hour to days later is delayed. Usually mild and probably not a true allergy. Did they have a fever, cold or virus at that time? Viral rashes are often misattributed to antibiotics, and we shouldn't be treating viruses with antibiotics anyway, so get good at looking at ears and know what you're seeing. And have they taken similar antibiotics since then? Like. Different penicillins, Augmentin, or cephalexin. So if they said that they were allergic to amoxicillin, but then somehow tolerated Augmentin. They're not allergic. If a patient had rash only, but no hive swelling or difficulty breathing, no reaction within the first hour. It occurred more than five years ago or before the kid was three. And especially if they tolerated beta-lactam antibiotics. Since then, they're a great candidate for de labeling and I would refer that kid to the allergy clinic. Generally, they can get them in pretty darn quick. Alright, we're gonna wrap up this episode. Most kids labeled penicillin allergic or amoxicillin allergic, or not actually allergic to the medication. There are some scores like pen fasts that are validated tools to assess risk and support de labeling. Direct oral challenge for most patients is safe, efficient, and increasingly the standard of care. There are allergy clinics like the Pats at Cincinnati Children's that can dela children in a single visit with oral challenges alone, needing no skin testing, and emergency departments can play a key role in identifying and referring these patients and possibly de labeling ourselves in the future. Well, that's all for this episode on Penicillin Allergy. I hope you learn something new, especially how to assess whether an allergy label is real, how to ask the right questions and when to refer to an allergy testing clinic. If you have feedback, send it my way. Email, comment on the blog, a message on social media. I always appreciate hearing from you all, and if you like this episode, please leave a review on your favorite podcast app. Really helps more people find the show and that's great 'cause I like to teach people stuff. Thanks for listening for PEM Currents, the Pediatric Emergency Medicine podcast. This has been Brad Sobolewski. See you next time.
Announcements: We're still here! Follow-ups: OK schools @4:35 Markwayne Mullin @5:36 Kimmel @6:58 Sinclair and Nexstar TX teachers “complying” @18:17 News: Kirk memorial @20:22 OK Republicans propose colleges must have Charlie Kirk statue @23:044 Pentagon restrictions on media @26:12 Chicago swim @28:05 Politics: Tom Homan's big bag'o'cash @30:55 RFK Jr. has appointed five new members to (ACIP) @35:50 Autism announcement @36:31 Axios write-up: “a large study concluded there was no connection.” @36:43 RFK Jr. Announces FDA Will Approve Leucovorin sold by iherb @40:11 Health/Medicine/Science: Vaccine meeting @44:18 The national trade association issued a statement American Academy of Pediatrics reiterated its support for existing vaccination schedule. a new “MAHA” report included “128 ideas, but few details” @46:25 Axios notes the initial response “revealed continued divisions within the MAHA” FDA to present data it claims ties Covid shots to child deaths @49:37 Censorship returns to the CDC. At least 22 websites are down. @51:36 EPA orders some scientists to stop publishing research Religious Nonsense: Nigerian court case @53:18 Final Stories: Stuck in Traffic, Emmanuel Macron Calls Trump @55:48 We're still here! @59:39
Paroxysmal movement disorders refer to a group of highly heterogeneous disorders that present with attacks of involuntary movements without loss of consciousness. These disorders demonstrate considerable and ever-expanding genetic and clinical heterogeneity, so an accurate clinical diagnosis has key therapeutic implications. In this episode, Kait Nevel, MD, speaks with Abhimanyu Mahajan, MD, MHS, FAAN, author of the article “Paroxysmal Movement Disorders” in the Continuum® August 2025 Movement Disorders issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Mahajan is an assistant professor of neurology and rehabilitation medicine at the James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders at the University of Cincinnati in Cincinnati, Ohio. Additional Resources Read the article: Paroxysmal Movement Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Guest: @MahajanMD Full episode transcript available here Dr Jones: This is Doctor Lyell Jones, editor in chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kait Nevel. Today I'm interviewing doctor Abhi Mahajan about his article on diagnosis and management of paroxysmal movement disorders, which appears in the August 2025 Continuum issue on movement disorders. Abhi, welcome to the podcast and please introduce yourself to the audience. Dr Mahajan: Thank you, Kait. Thank you for inviting me. My name is Abhi Mahajan. I'm an assistant professor of neurology and rehabilitation medicine at the University of Cincinnati in Cincinnati, Ohio. I'm happy to be here. Dr Nevel: Wonderful. Well, I'm really excited to talk to you about your article today on this very interesting and unique set of movement disorders. So, before we get into your article a little bit more, I think just kind of the set the stage for the discussion so that we're all on the same page. Could you start us off with some definitions? What are paroxysmal movement disorders? And generally, how do we start to kind of categorize these in our minds? Dr Mahajan: So, the term paroxysmal movement disorders refers to a group of highly heterogeneous disorders. These may present with attacks of involuntary movements, commonly a combination of dystonia and chorea, or ataxia, or both. These movements are typically without loss of consciousness and may follow, may follow, so with or without known triggers. In terms of the classification, these have been classified in a number of ways. Classically, these have been classified based on the trigger. So, if the paroxysmal movement disorder follows activity, these are called kinesigenic, paroxysmal, kinesigenic dyskinesia. If they are not followed by activity, they're called non kinesigenic dyskinesia and then if they've followed prolonged activity or exercise they're called paroxysmal exercise induced dyskinesia. There's a separate but related group of protogynous movement disorders called episodic attacks here that can have their own triggers. Initially this was the classification that was said. Subsequent classifications have placed their focus on the ideology of these attacks that could be familiar or acquired and of course understanding of familiar or genetic causes of paroxysmal movement disorders keeps on expanding and so on and so forth. And more recently, response to pharmacotherapy and specific clinical features have also been introduced into the classification. Dr Nevel: Great, thank you for that. Can you share with us what you think is the most important takeaway from your article for the practicing neurologist? Dr Mahajan: Absolutely. I think it's important to recognize that everything that looks and sounds bizarre should not be dismissed as malingering. Such hyperkinetic and again in quotations, “bizarre movements”. They may appear functional to the untrained eye or the lazy eye. These movements can be diagnosed. Paroxysmal movement disorders can be diagnosed with a good clinical history and exam and may be treated with a lot of success with medications that are readily available and cheap. So, you can actually make a huge amount of difference to your patients' lives by practicing old-school neurology. Dr Nevel: That's great, thank you so much for that. I can imagine that scenario does come up where somebody is thought to have a functional neurological disorder but really has a proximal movement disorder. You mentioned that in your article, how it's important to distinguish between these two, how there can be similarities at times. Do you mind giving us a little bit more in terms of how do we differentiate between functional neurologic disorder and paroxysmal movement disorder? Dr Mahajan: So clinical differentiation of functional neurological disorder from paroxysmal movement disorders, of course it's really important as a management is completely different, but it can be quite challenging. There's certainly an overlap. So, there can be an overlap with presentation, with phenomenology. Paroxysmal nature is common to both of them. In addition, FND and PMD's may commonly share triggers, whether they are movement, physical exercise. Other triggers include emotional stimuli, even touch or auditory stimuli. What makes it even more challenging is that FND's may coexist with other neurological disorders, including paroxysmal movement disorders. However, there are certain specific phenom phenotypic differences that have been reported. So specific presentations, for example the paroxysms may look different. Each paroxysm may look different in functional neurological disorders, specific phenotypes like paroxysmal akinesia. So, these are long duration episodes with eyes closed. Certain kinds of paroxysmal hyperkinesia with ataxia and dystonia have been reported. Of course. More commonly we see PNES of paroxysmal nonepileptic spells or seizures that may be considered paroxysmal movement disorders but represent completely different etiology which is FND. Within the world of movement disorders, functional jerks may resemble propiospinal myoclonus which is a completely different entity. Overall, there are certain things that help separate functional movement disorders from paroxysmal movement disorders, such as an acute onset variable and inconsistent phenomenology. They can be suggestibility, distractibility, entrainment, the use of an EMG may show a B-potential (Bereitschaftspotential) preceding the movement in patients with FND. So, all of these cues are really helpful. Dr Nevel: Great, thanks. When you're seeing a patient who's reporting to these paroxysmal uncontrollable movements, what kind of features of their story really tips you off that this might be a proximal movement disorder? Dr Mahajan: Often these patients have been diagnosed with functional neurological disorders and they come to us. But for me, whenever the patient and or the family talk about episodic movements, I think about these. Honestly, we must be aware that there is a possibility that the movements that the patients are reporting that you may not see in clinic. Maybe there are obvious movement disorders. Specifically, there's certain clues that you should always ask for in the history, for example, ask for the age of onset, a description of movements. Patients typically have videos or families have videos. You may not be able to see them in clinic. The regularity of frequency of these movements, how long the attacks are, is there any family history of or not? On the basis of triggers, whether, as I mentioned before, do these follow exercise? Prolonged exercise? Or neither of the above? What is the presentation in between attacks, which I think is a very important clinical clue. Your examination may be limited to videos, but it's important not just to examine the video which represents the patient during an attack, but in between attacks. That is important. And of course, I suspect we'll get to the treatment, but the treatment can follow just this part, the history and physical exam. It may be refined with further testing, including genetic testing. Dr Nevel: Great. On the note of genetic testing, when you do suspect a diagnosis of paroxysmal movement disorder, what are some key points for the provider to be aware of about genetic testing? How do we go about that? I know that there are lots of different options for genetic testing and it gets complicated. What do you suggest? Dr Mahajan: Traditionally, things were a little bit easier, right, because we had a couple of genes that have been associated with the robust movement disorders. So, genetic testing included single gene testing, testing for PRRT2 followed by SLC2A. And if these were negative, you said, well, this is not a genetic ideology for paroxysmal movement disorders. Of course, with time that has changed. There's an increase in known genes and variants. There is increased genetic entropy. So, the same genetic mutation may present with many phenotypes and different genetic mutations may present with the similar phenotype. Single gene testing is not a high yield approach. Overall genetic investigations for paroxysmal movement disorders use next generation sequencing or whole exome sequence panels which allow for sequencing of multiple genes simultaneously. The reported diagnostic yield with let's say next generation sequencing is around 35 to 50 percent. Specific labs at centers have developed their own panels which may improve the yield of course. In children, microarray may be considered, especially the presentation includes epilepsy or intellectual disability because copy number variations may not be detected by a whole exome sequencing or next generation sequencing. Overall, I will tell you that I'm certainly not an expert in genetics, so whenever you're considering genetic testing, if possible, please utilize the expertise of a genetic counsellor. Families want to know, especially as an understanding of the molecular underpinnings and knowledge about associated mutations or variations keeps on expanding. We need to incorporate their expertise. A variant of unknown significance, which is quite a common result with genetic testing, may not be a variant of unknown significance next year may be reclassified as pathogenic. So, this is extremely important. Dr Nevel: Yeah. That's such a good point. Thank you. And you just mentioned that there are some genetic mutations that can lead to multiple different phenotypes. Seemingly similar phenotypes can be associated with various genetic mutations. What's our understanding of that? Do we have an understanding of that? Why there is this seeming disconnect at times between the specific genetic mutation and the phenotype? Dr Mahajan: That is a tough question to answer for all paroxysmal movement disorders because the answer may be specific to a specific mutation. I think a great example is the CACNA1A mutation. It is a common cause of episodic ataxia type 2. Depending on when the patient presents, you can have a whole gamut of clinical presentations. So, if the patient is 1 year old, the patient can present with epileptic encephalopathy. Two to 5 years, it can be benign paroxysmal torticollis of infancy. Five to 10 years, can present with learning difficulties with absence epilepsy and then of course later, greater than 10 years, with episodic ataxia (type) 2 hemiplegic migraine and then a presentation with progressive ataxia and hemiplegic migraines has also been reported. So not just episodic progressive form of ataxia has also been reported. I think overall these disorders are very rare. They are even more infrequently diagnosed than their prevalence. As such, the point that different genetic mutations present with different phenotypes, or the same genetic mutation I may present with different phenotypes could also represent this part. Understanding of the clinical presentation is really incomplete and forever growing. There's a new case report or case series every other month, which makes this a little bit challenging, but that's all the more reason for learning about them and for constant vigilance for patients who show up to our clinic. Dr Nevel: Yeah, absolutely. What is our current understanding of the associated pathophysiology of these conditions and the pathophysiology relating to the genetics? And then how does that relate to the treatment of these conditions? Dr Mahajan: So, a number of different disease mechanisms have been proposed. Traditionally, these were all thought to be ion channelopathies, but a number of different processes have been proposed now. So, depending on the genetic mutation that you talk about. So certain mutations can involve ion channels such as CACMA1A, ATP1A3. It can involve solute carriers, synaptic vesicle fusion, energy metabolism such as ECHS1, synthesis of neurotransmitters such as GCH1. So, there are multiple processes that may be involved. I think overall for the practicing clinician such as me, I think there is a greater need for us to understand the underlying genetics and associated phenotypes and the molecular mechanisms specifically because these can actually influence treatment decisions, right? So, you mentioned that specific genetic testing understanding of the underlying molecular mechanism can influence specific treatments. As an example, a patient presenting with proximal nocturnal dyskinesia with mutation in the ADCY5 gene may respond beautifully to caffeine. Other examples if you have SLC2A1, so gluc-1 (glucose transporter type 1) mutation, a ketogenic diet may work really well. If you have PDHA1 mutation that may respond to thiamine and so on and so forth. There are certain patients where paroxysmal movement disorders are highly disabling and you may consider deep brain stimulation. That's another reason why it may be important to understand genetic mutations because there is literature on response to DBS with certain mutations versus others. Helps like counselling for patients and families, and of course introduces time, effort, and money spent in additional testing. Dr Nevel: Other than genetic testing, what other diagnostic work up do you consider when you're evaluating patients with a suspected paroxysmal movement disorder? Are there specific things in the history or on exam that would prompt you to do certain testing to look for perhaps other things in your differential when you're first evaluating a patient? Dr Mahajan: In this article, I provide a flow chart that helps me assess these patients as well. I think overall the history taking and neurological exam outside of these paroxysms is really important. So, the clinical exam in between these episodic events, for example, for history, specific examples include, well, when do these paroxysms happen? Do they happen or are they precipitated with meals that might indicate that there's something to do with glucose metabolism? Do they follow exercise? So, a specific example is in Moyamoya disease, they can be limb shaking that follows exercise. So, which gives you a clue to what the etiology could be. Of course, family history is important, but again, talking about the exam in between episodes, you know, this is actually a great point because out– we've talked about genetics, we've talked about idiopathic paroxysmal movement disorders, –but a number of these disorders are because of acquired causes. Well, of course it's important because acquired causes such as autoimmune causes, so multiple sclerosis, ADEM, lupus, LGI1, all of these NMDAR, I mentioned Moyamoya disease and metabolic causes. Of course, you can consider FND as under-acquired as well. But all of these causes have very different treatments and they have very different prognosis. So, I think it's extremely important for us to look into the history with a fine comb and then examine these patients in between these episodes and keep our mind open about acquired causes as well. Dr Nevel: When you evaluate these patients, are you routinely ordering vascular imaging and autoimmune kind of serologies and things like that to evaluate for these other acquired causes or it does it really just depend on the clinical presentation of the patient? Dr Mahajan: It mostly depends on the clinical presentation. I mean, if the exam is let's say completely normal, there are no other risk factors in a thirty year old, then you know, with a normal exam, normal history, no other risk factors. I may not order an MRI of the brain. But if the patient is 55 or 60 (years) with vascular risk factors, then you have to be mindful that this could be a TIA. If the patient has let's say in the 30s and in between these episodes too has basically has a sequel of these paroxysms, then you may want to consider autoimmune. I think the understanding of paraneoplastic, even autoimmune disorders, is expanding as well. So, you know the pattern matters. So, if all of this is subacute started a few months ago, then I have a low threshold for ordering testing for autoimmune and paraneoplastic ideology is simply because it makes such a huge difference in terms of how you approach the treatment and the long-term prognosis. Dr Nevel: Yeah, absolutely. What do you find most challenging about the management of patients with paroxysmal movement disorders? And then also what is most rewarding? Dr Mahajan: I think the answer to both those questions is, is the same. The first thing is there's so much advancement in what we know and how we understand these disorders so regularly that it's really hard to keep on track. Even for this article, it took me a few months to write this article, and between the time and I started and when I ended, there were new papers to include new case reports, case series, right? So, these are rare disorders. So most of our understanding for these disorders comes from case reports and case series, and it's in a constant state of advancement. I think that is the most challenging part, but it's also the most interesting part as well. I think the challenging and interesting part is the heterogeneity of presentation as well. These can involve just one part of your body, your entire body can present with paroxysmal events, with multiple different phenomenologies and they might change over time. So overall, it's highly rewarding to diagnose such patients in clinic. As I said before, you can make a sizeable difference with the medication which is usually inexpensive, which is obviously a great point to mention these days in our health system. But with anti-seizure drugs, you can put the right diagnosis, you can make a huge difference. I just wanted to make a point that this is not minimizing in any way the validity or the importance of diagnosing patients with functional neurological disorders correctly. Both of them are as organic. The importance is the treatment is completely different. So, if you're diagnosing somebody with FND and they do have FND and they get cognitive behavioral therapy and they get better, that's fantastic. But if somebody has paroxysmal movement disorders and they undergo cognitive behavioral therapy and they're not doing well, that doesn't help anybody. Dr Nevel: One hundred percent. As providers, obviously we all want to help our patients and having the correct diagnosis, you know, is the first step. What is most interesting to you about paroxysmal movement disorders? Dr Mahajan: So outside of the above, there are some unanswered questions that I find very interesting. Specifically, the overlap with epilepsy is very interesting, including shared genes, the episodic nature, presence of triggers, therapeutic response to anti-seizure drugs. All of this I think deserves further study. In the clinic, you may find that epilepsy and prognosis for movement disorders may occur in the same individual or in a family. Episodic ataxia has been associated with seizures. Traditionally this dichotomy of an ictal focus. If it's cortical then it's epilepsy, if it's subcortical then it's prognosis for movement disorders. This is thought to be overly simplistic. There can be co-occurrence of seizures and paroxysmal movement disorders in the same patient and that has led to this continuum between these two that has been proposed. This is something that needs to be looked into in more detail. Our colleagues in Epilepsy may scoff this, but there's concept of basal ganglia epilepsy manifesting as paroxysmal movement disorders was proposed in the past. And there was this case report that was published out of Italy where there was ictal discharge from the supplementary sensory motor cortex with a concomitant discharge from the ipsilateral coordinate nucleus in a patient with paroxysmal kinesigenic cardioarthidosis. So again, you know, basal ganglia epilepsy, no matter what you call it, the idea is that there is a clear overlap between these two conditions. And I think that is fascinating. Dr Nevel: Really interesting stuff. Well, thank you so much for chatting with me today. Dr Mahajan: Thank you, Kait. And thank you to the Continuum for inviting me to write this article and for this chance to speak about it. I'm excited about how it turned out, and I hope readers enjoy it as well. Dr Nevel: Today again, I've been interviewing doctor Abhi Mahajan about his article on diagnosis and management of paroxysmal movement disorders, which appears in the August 2025 Continuum issue on movement disorders. I encourage all of our listeners to be sure to check out the Continuum Audio episodes from this and other issues. As always, please read the Continuum articles where you can find a lot more information than what we were able to cover in our discussion today. And thank you for our listeners for joining today. And thank you, Abhi, so much for sharing your knowledge with us today. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.
In the final episode of our congenital heart disease and neurodevelopment series, host Paul Wirkus, MD, FAAP, is joined by experts Kristi Glotzbach, MD, Sarah Winter, MD, and Laura Wood, PhD. Together, they answer listener questions and share practical resources to help providers support children with CHD and related developmental challenges. Have a question? Email questions@vcurb.com.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP. Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Episode Summary:In this compelling episode of the Pain Matters Podcast, hosts Sudheer Potru, DO, FASA, FASAM, and Zafeer Baber, MD, sit down with Jeremy Adler, DMSc, PA-C, DFAAPA, a seasoned Physician Assistant practicing at the UCSD Center for Pain Medicine in the field of pain medicine, to explore the evolving roles of advanced practice providers in the specialty. Jeremy shares insights from his 25-year career spanning private practice and academia, shedding light on the benefits and challenges of working in these different professional settings. Jeremy Adler's engaging discussion highlights the multidimensional nature of medicine, emphasizing the importance of a multidisciplinary approach that includes APPs, anesthesiologists, psychologists, and more. This episode delves into the reasons behind the rising interest in APP roles, fueled by the pursuit of work-life balance and diverse practice opportunities across specialties. The conversation also explores the necessity of formalized education and training to equip PAs and NPs with the skills needed to excel in the complex landscape of pain medicine.About the GuestJeremy A. Adler, DMSc, PA-C, DFAAPA|Dr. Jeremy Adler is a nationally recognized physician assistant with over 25 years of experience in pain management. He serves at UC San Diego Health's Center for Pain Medicine and previously co-owned a private pain practice. A published author and national lecturer, he's known for his advocacy in evidence-based, compassionate pain care and has earned honors including California State Assembly recognition and POCN's 2022 Top Pain Management PA award. He also leads the American Academy of Pain Medicine Foundation and holds leadership roles in major professional organizations.
In this episode of Occupied Thoughts, FMEP Fellow Peter Beinart speaks with UC Berkeley Professor Ussama Makdisi, who was recently informed that UC Berkeley shared his name, along with those of 159 other Berkeley faculty & students, with the federal government for "alleged incidents of antisemitism." Peter & Ussama discuss the absurdity of experience -- the accused have not been informed of any details of the allegations against them -- while looking at why UC Berkeley is not defending its faculty and students, how the Berkeley experience compares with how other universities have capitulated to the Trump administration, and whether academic freedom on campus will survive. Most urgently, they discuss how the attacks on universities are meant to distract from the genocide Israel is carrying out right now against Palestinians. Resources on this topic include "UC Berkeley shares 160 names with Trump administration in ‘McCarthy era' move," The Guardian 9/12/25; "UC Berkeley professor warns of 'unprecedented crackdown' on academic freedom." NPR interview with Ussama Makdisi on 9/18/25 "When Universities Become Informants," by Judith Butler, 9/13/25 "Kafka-land at UC Berkeley," by Judith Butler, The Nation, 9/16/25 Dr. Ussama Makdisi is Professor of History and Chancellor's Chair at the University of California Berkeley. He was previously Professor of History and the first holder of the Arab-American Educational Foundation Chair of Arab Studies at Rice University in Houston. During AY 2019-2020, Professor Makdisi was a Visiting Professor at the University of California at Berkeley in the Department of History. Makdisi was awarded the Berlin Prize and spent the Spring 2018 semester as a Fellow at the American Academy of Berlin. Professor Makdisi's most recent book Age of Coexistence: The Ecumenical Frame and the Making of the Modern Arab World was published in 2019 by the University of California Press. He is also the author of Faith Misplaced: the Broken Promise of U.S.-Arab Relations, 1820-2001 (Public Affairs, 2010). His previous books include Artillery of Heaven: American Missionaries and the Failed Conversion of the Middle East (Cornell University Press, 2008), which was the winner of the 2008 Albert Hourani Book Award from the Middle East Studies Association, the 2009 John Hope Franklin Prize of the American Studies Association, and a co-winner of the 2009 British-Kuwait Friendship Society Book Prize given by the British Society for Middle Eastern Studies. Makdisi is also the author of The Culture of Sectarianism: Community, History, and Violence in Nineteenth-Century Ottoman Lebanon (University of California Press, 2000) and co-editor of Memory and Violence in the Middle East and North Africa (Indiana University Press, 2006). He has published widely on Ottoman and Arab history as well as on U.S.-Arab relations and U.S. missionary work in the Middle East. Peter Beinart is a Non-Resident Fellow at the Foundation for Middle East Peace. He is also a Professor of Journalism and Political Science at the City University of New York, a Contributing opinion writer at the New York Times, an Editor-at-Large at Jewish Currents, and an MSNBC Political Commentator. His newest book (published 2025) is Being Jewish After the Destruction of Gaza: A Reckoning. Original music by Jalal Yaquoub.
Our guest today, Dr. Chris Walinski, is a dentist, researcher, MasterChef contestant, and prostate cancer survivor. His story is an inspiring one of persistence, adaptation, reinvention and turning adversity into advocacy. Chris shares how his childhood independence led to a lifelong passion for cooking, how his wife nudged him into the MasterChef spotlight, and how a life-altering cancer diagnosis reshaped his perspective on food, prevention, and living fully. You'll learn: - What Chris learned from competing on MasterChef (and from Gordon Ramsay...) - How his cancer journey shifted his mindset on prevention, nutrition, and resilience - The role of antioxidants, anti-inflammatory foods, and gut health in longevity - The top prostate-friendly foods - The importance of cutting back on ultra-processed foods, red meat, alcohol, and sugar - Chris's lessons on reinvention in midlife and retirement ________________________ Bio Dr. Chris Walinski has been an author, inventor and trusted expert in dentistry for over 25 years and has authored a dental text that has been translated into 10 languages. He is one of the earliest dentists to use lasers in dentistry, Dr. Walinski has been called upon to make presentations around the world at professional conferences and universities. Since 2004, he has taught thousands of doctors on the topics of cosmetics, minimally-invasive dentistry, technology and the use of lasers. His lectures have taken him to almost 50 countries at this point. Dr. Walinski is the Executive Director of the World Clinical Laser Institute and the International Dental Laser Research Institute, and is a Founding member of the American Academy of Oral Systemic Health. He is a Diplomate and Past-President of the World Congress of Minimally Invasive Dentistry. He is a proud member of Sigma Xi, the Scientific Research Honor Society, and his Fellowships include the International College of Dentists, The Royal Society of Medicine, The International Association for Laser Dentistry and the American Society for Lasers in Medicine and Surgery. Dr. Walinski's lifelong love of cooking resulted in him competing on this season's MasterChef on FOX. He also has three lovely children and is married to the love of his life and wife of six years. They live together with their English Springer Spaniel, Lacey. _________________________ For More on Chris Walinski The Prostate Site 3 recipes to try: ‘MasterChef' alum's cake, soup, rice - Ohio State Alumni Magazine _________________________ Prostate Cancer Testing Free Prostate Cancer Testing Near You NFL Crucial Catch - FIND A CANCER SCREENING LOCATION NEAR YOU* _________________________ Podcast Conversations You May Like How Not to Age – Dr. Michael Greger The Well-Lived Life – Dr. Gladys McGarey Take Charge of Your Well-Being – John La Puma, MD _________________________ About The Retirement Wisdom Podcast There are many podcasts on retirement, often hosted by financial advisors with their own financial motives, that cover the money side of the street. This podcast is different. You'll get smarter about the investment decisions you'll make about the most important asset you'll have in retirement: your time. About Retirement Wisdom I help people who are retiring, but aren't quite done yet, discover what's next and build their custom version of their next life. A meaningful retirement doesn't just happen by accident. Schedule a call today to discuss how the Designing Your Life process created by Bill Burnett & Dave Evans can help you make your life in retirement a great one — on your own terms. About Your Podcast Host Joe Casey is an executive coach who helps people design their next life after their primary career and create their version of The Multipurpose Retirement.™ He created his own next chapter after a 26-year career at Merrill Lynch, where he was Senior Vice President and Head of HR for Global Markets & Investment ...